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Introduction 
 
 
1.) The Importance of Separating Enantiomers 
 
Chiral compounds – molecules that have no internal symmetry plane or centers of in-
version and are non-superimposable on their mirror images - constitute a large part of 
modern drugs: 
According to Caner, more than half of all drugs approved by the FDA in 1991-2002 are 
chiral and are administered as racemates or single enantiomers,1 with the latter gaining 
importance rapidly.2 
Nowadays, it is well known that the enantiomers of a chiral compound can differ dra-
matically in their respective effects on the human body.  
Usually one enantiomer (the eutomer) of a chiral compound has the desired therapeutic 
effect, while the other (the distomer) can have no effect at all, a therapeutic effect 
smaller or in other ways different from that of the eutomer, or even an undesired effect. 
A prominent example of the latter is the chiral drug Thalidomide (Figure 1).  
 
N
O
O
NH
O
O N
O
O
HN
O
O
S R  
Fig.1: Enantiomers of Thalidomide. The R enantiomer has a sedating effect, while 
the S enantiomer causes severe deformities in unborn children. 
 
Its racemic mixture enantiomer was administered to pregnant women in the 1950s and 
1960s as a mild sedative and a remedy against morning sickness. Even if only the R 
enantiomer had been used, the tragedy would not have been prevented because, unfor-
tunately, inside the human body it can be converted into the S enantiomer which has 
severe teratogenic effects. As a result, more than 10 000 babies in 46 countries were 
born with serious physical deformities.3 
 
Nevertheless, drugs are frequently administered as racemates or mixtures of stereoi-
somers, especially if no appropriate asymmetric synthesis protocol is available and en-
antiomer separation is unreasonably labour-intensive or expensive. 
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In those cases, regulatory laws require that the manufacturer determine the enantio-
meric composition of the product (enantiomeric excess levels of > 99,9 %) . Further-
more, the distomer must be proven to be non-hazardous. 
It is obvious that to fulfil these requirements, enantiomerically pure samples of both en-
antiomers are necessary. This is when enantioselective analysis techniques (also 
termed chiral separation methods) are called for. 
 
Since the 1990s, rigorous regulatory demands have further enhanced the need for re-
producible, efficient and highly selective enantiomer separation methods. 
Scientists dealing with the development of such techniques had to face a challenging 
task:  
As two enantiomers of a chiral compound consist of exactly the same atoms, bonded in 
the same way and with the same interatomic distances, their scalar physical properties 
such as molecular weights, melting points and internal energies are exactly alike. This 
makes them indistinguishable with “classical” achiral detectors such as UV, fluores-
cence or MS. 
The only way to differentiate between enantiomers is to create a chiral environment, 
meaning interaction sites where the analyte can get in contact with another chiral com-
pound. Besides, circularly polarised light can be used to create optical rotation whose 
orientation is different for the two enantiomers of a chiral molecule. Thus, it can be seen 
as a chiral source and environment. 
 
 
 
 
 
 
2.) Enantiomer Separation Methods 
 
In stereochemical analysis it is often required to transform enantiomers (the selectands, 
SA) by using chiral selectors (SO) to create diastereomeric complexes which can be 
separated and detected with conventional methods (Figure 2).4  
 [ ]
[ ]))()()()(
))()()()(
SARSORSARSOR
SASSORSASSOR
R
S
K
K
−−−⎯→←−+−
−−−⎯→←−+−
 
 
Fig. 2: Formation of diastereomeric complexes from an enantiomerically pure selec-
tor ((R) –SO) and enantiomers of a selectand ((S)-SA, (R)-SA). 
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The formation of diastereomeric entities can be covalent or due to number of different 
non-covalent interaction forces. 
A large number of chiral separation techniques have been developed to separate the 
enantiomers of diverse groups of chemical compounds such as amines, alcohols, acids 
and bases. 
 
The methods are classified primarily as “direct” or “indirect” separation techniques, ac-
cording to the type of diastereomeric complexes that are formed. 
 
 
2.1) The Indirect Approach 
 
In the course of indirect chiral separations, the selectand enantiomers are converted 
into covalently bonded SO-SA diastereomers with an enantiomerically pure auxiliary 
(chiral derivatising agent, CDA). The resulting molecules are diastereomers of each 
other and can be separated relatively easily, for example with conventional achiral 
chromatographic methods such as RP-HPLC. 
 
Indirect separation techniques have a long-standing tradition and therefore, chiral deri-
vatising agents for all kinds of derivatisable functional groups are available.5 
They must fulfil certain requirements concerning their chemical and physical stability. 
Besides, they should be commercially available with very high enantiomeric purity, pref-
erably in both enantiomeric forms to enable the reversal of elution order. They should 
contain appropriate functional groups to facilitate the chosen separation method (e.g. 
hydrophobic groups for RP-HPLC) and chromophoric or fluorophoric groups for easy 
detection. 
 
Figure 3 shows two commercially available chiral derivatising agents and their applica-
tions. 
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Fig. 3: Chiral derivatising agents (CDAs) a Mosher´s reagent for amines and alcohols 
b OPA (ortho-phthaldialdehyde) with chiral thiol for primary amines and amino acids 
 
 
 
However, there are also several drawbacks to the indirect approach, e.g. the required 
existence of derivatisable functional groups (hydroxyl, amine, carbonyl, etc.) in the se-
lectand. 
The derivatising agent must be of particularly high enantiomeric purity, otherwise a total 
of 4 stereoisomers will be formed, of which two are enantiomers of the other two. This 
means that they would not be separable with classical methods and thus, the analytical 
results would be compromised. 
If the reaction rates of the enantiomers for the derivatisation reaction are different, ki-
netic racemate solution can occur. Therefore, it is of utmost importance to use a CDA 
that allows reasonably fast conversion and to wait for the completion of the reaction. 
The detector response might be different for the diastereomers, which can lead to prob-
lems with quantitative analyses.6 
 
 
Due to these restrictions, indirect chiral separation methods are of minor importance 
compared to direct ones. 
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2.2) The Direct Approach 
 
A reversible formation of diastereomeric molecule associates based on non-covalent 
interactions is the principle of the direct approach to the separation of enantiomers. 
Again, the selectand enantiomers are brought into contact with a chiral auxiliary, the 
selector (SO). The reaction partners can interact in different ways according to their 
functional groups and their stereochemistries, which will lead to the discrimination of 
one enantiomer.  
Chiral recognition is based on electrostatic (ionic or dipole-dipole) interactions, hydro-
gen bonds, hydrophobic interactions or π−π interactions between the selector and the 
enantiomers of the selectand. Frequently, a combination of some or all of the interac-
tions mentioned is responsible for the separation. 
 
As indicated above, the enantiomers of a chiral compound will interact differently with a 
chiral selector due to their stereochemical properties.  
The 3-point interaction model created by K. Dalgliesh is most suitable to illustrate enan-
tiodiscrimination (Figure 4). 
The spatial arrangement of the molecule on the left matches the interaction sites A´, 
B´and C´ of the selector, whereas its enantiomer on the right cannot interact as effec-
tively with the selector. The molecule associates that are formed differ in their stability 
and thus, enantiodiscrimination is achieved. 
 
 
 
Fig. 4: 3-point interaction model. Left: The molecule matches the active sites of the 
selector. Right: Its enantiomer does not match the selector and is therefore discrimi-
nated. 7
 
Even though some GC applications exist, the direct approach to enantiomer separation 
is most often realised in liquid chromatographic methods, such as chiral HPLC. 
The selector can either be added to the mobile phase (chiral mobile phase mode, CMP) 
or it can be covalently liked to or otherwise integrated into the stationary phase (chiral 
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stationary phase mode, CSP). The latter is by far the most used chiral separation tech-
nique today, with more than 100 chiral stationary phases for all kinds of analytes com-
mercially available from a number of suppliers. 4 
 
 
Figure 5 provides an overview of modern chiral stationary phases. 
 
 
Type of selector Examples  Analytes 
 
 
Polysaccharides 
 
cellulose 
 
amylose 
 
chemically modified polysaccha-
rides 
 
 
 
acidic, basic, neutral 
 
broadest applicability! 
Synthetic polymers poly(triphenylmethacrylate) 
 
 
Proteins HSA 
 
AGP 
 
ovomucoid 
 
acidic 
 
 
broad applicability 
Cyclodextrines α-CD 
 
β-CD 
 
γ-CD 
 
chemically modified CDs 
 
smaller hydrophobic 
analytes 
 
substituted phenyl, 
naphthyl, heteroaromatic 
rings 
steroids 
Macrocyclic antibiotics vancomycin 
 
teicoplanine 
 
ristocetin A 
 
aglycones 
 
 
amines 
 
amino acids, peptides 
 
bases 
 
Chiral crown ethers aryl and tartaric acid-derived 
crown ethers 
 
1° and 2° amines 
 
Fig. 5: A selection of modern chiral stationary phases and their applications 
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Type of selector Examples  Analytes 
Donor-acceptor phases 
(brush-type or Pirkle-type 
phases) 
Whelk-O1TM 
(4-(3,5-dinitrobanzamido)-
1,2,3,4-tetrahydrophenanthrene) 
ULMOTM 
 
(11-[2-(3,5-dinitrobenzamido)-
1,2-diphenylethylamino]-11-
oxoundecyl-silica8 
 
 
Naproxen, pharmaceuticals 
 
 
aryl carbinols and many 
other compounds 
Chiral ion exchangers cinchona alkaloid derivatives 
 
carboxylic and sulfonic acid de-
rivatives 
chiral acids 
 
chiral bases 
 
 
 
  
Fig. 5 (continued): A selection of modern chiral stationary phases and their applica-
tions 
 
 
 
 
 
 
 
3.) Separation of Amino Acids and Peptides 
 
The separation of chiral acids and bases can be achieved most elegantly with chiral ion 
exchangers based, for example, on cinchona alkaloids and sulfonic acids, respectively 
(Figure 6).9 
 
 
 
 
a 
 
 
 
b 
Fig. 6: a Anion exchange CSP based on cinchona alkaloid quinine for the enanti-
omer separation of chiral acids X b cation exchange CSP based on a chiral sulfonic 
acid for the separation of chiral bases Y. 
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But what do chemists do when the analyte that they want to separate into its enanti-
omers has both acidic and basic functional groups, as is the case with several drugs, 
amino acids and peptides? 
The latter two are essential ingredients of life: 22 so-called proteinogenic amino acids 
consisting of a carboxyl function, an α-amino group and a variable side chain (Figure 7) 
are the main building blocks of the proteins in our bodies. Interestingly, they all are α-
amino acids and they all have L-configuration (except for glycine, which is achiral).  
 
OH
O
NH2
R *
 
 
Fig. 7: α-amino acid structure. The asterisk marks the α position which is asymmet-
ric in most amino acids. 
 
 
Apart from the proteinogenic amino acids, a number of other amino acids are to be 
found in plants and microorganisms. These amino acids can have D configuration (often 
found in bacteria cell walls) or an amino group in β or γ position. 
 
Proteinogenic amino acids can be classified by the properties of their side chains: 10 
 
aliphatic amino acids glycine (Gly), alanine (Ala), Valine (Val), leucine (Leu), 
isoleucine (Ile), proline (Pro) 
 
aliphatic amino acids 
containing sulphur 
 
methionine (Met), Cysteine (Cys) 
aromatic amino acids 
 
phenylalanine (Phe), tyrosine (Tyr), tryptophane (Trp) 
polar uncharged 
amino acids 
 
serine (Ser), threonine (Thr), asparagine (Asn), glutamine 
(Gln) 
basic amino acids 
(positively charged) 
 
lysine (Lys), arginine (Arg), histidine (His) 
acidic amino acids 
(negatively charged) 
 
aspartic acid (Asp), glutamic acid (Glu) 
 
 
Amino acids can undergo condensation reactions involving the carboxyl function of one 
and the amino group of another to form a peptide (amide) bond (Figure 8): 
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OH
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Fig. 8: Formation of a peptide bond between amino acids. 
 
 
 
By condensation of 2 or more amino acids, peptides (2-100 amino acid residues) and 
proteins (> 100 amino acid residues) are formed. 
 
 
Chiral separation techniques for amino acids and peptides are required to determine the 
enantiomeric purities of synthetic peptides and other asymmetric synthesis products. 
Under acidic or basic conditions, racemisation may occur. These processes, too, must 
be monitored by enantioselective analysis since D and L enantiomers of amino acids 
can differ in their biological activities and sensoric properties. For example, many L 
amino acids taste bitter, while their D enantiomers have a sweet taste. 11 
 
Due to the presence of both acidic (the carboxylic function) and basic (the amino group) 
moieties in amino acids and, therefore, peptides and proteins, these molecules are am-
photeric. Depending on the pH of the surrounding medium, they can exist as acids or 
bases, but most of the time the carboxylic function will be deprotonated and the amino 
function will be protonated. Thus, they will be outwardly neutral despite the presence of 
both positive and negative charges in the molecule. Such a compound is called zwitteri-
onic. 
The challenge of the enantioseparation of zwitterionic analytes is that it cannot be 
achieved by a conventional chiral anion or cation exchanger. The second charge pre-
sent in the analyte is of the same name as the ion exchanger and therefore prevents 
retention. To be precise, in ion exchange chromatography repulsion between charges of 
the same name leads to elution before the void volume marker. 
 
However, several other methods for the separation of amino acid and peptide enanti-
omers have been developed. The discussion will be limited to chromatographic applica-
tions as they represent the most successful approach to chiral separations.  
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3.1) Indirect Separation Methods for Amino Acids and Peptides 
 
Indirect enantioseparation aims at the conversion of enantiomers into diastereomeric 
molecules which are separable on an achiral stationary phase (see 2.1). 
 
The indirect approach to enantioseparation of amino acids is relatively popular due to a 
number of advantages12: Suitable chiral derivatising agents are available and the choice 
of chromatographic conditions to separate the resulting diastereomers ranges from RP 
to NP and GC applications. Besides, achiral columns can be used. 
Often both enantiomeric forms of a CDA can be purchased, which allows the reversal of 
elution orders – this can be of special interest if enantiomeric impurities (e.g. the D en-
antiomer of an amino acid) are to be determined – in chromatography, the impurity 
(usually the smaller peak) should be eluted from the column before the main analyte. 
Predicting elution orders is often easier when using indirect methods. Generally, method 
development may be achieved more quickly than with chiral stationary phases which 
often require laborious mobile phase optimisation. 
 
In addition to the drawbacks that have been discussed briefly in section 2.1., it should 
be mentioned here that the hydrolysis of peptides, as it is done to assess their chiral 
amino acid composition, can lead to racemisation (3.3) which might compromise the 
outcome of the analysis. 
 
For indirect enantioseparation, amino acids are most often converted into amides, car-
bamates, ureas and thioureas. Acid chlorides, chloroformates isocyanates and isothio-
cyanates are frequently used as CDAs. 
Figure 9 provides examples for the chiral derivatisation of proteinogenic amino acids. 
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Fig. 9: Chiral derivatising agents for amino acids 
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Fig. 3b 
Fig. 9 (continued): Chiral derivatising agents for amino acids 
 
 
 
It was mentioned before that it constitutes one of the major advantages of the indirect 
enantioseparation methods that by derivatising them, the scientist can introduce func-
tional groups which facilitate sensitive detection (a concept widely known as “labelling”). 
Therefore, many of the CDAs presented in Fig. 8 have aromatic substituents to enhance 
UV or fluorescence detection. 
 
The CDAs based on carboxylic acids usually need to be activated by conversion into 
their acid chlorides which then react with the amino acid analytes to form di-
astereomers. 
The chloroformate reagent FLEC is suitable for the chiral separation of primary and 
secondary amino acids and can also be used for chiral α-hydroxy acids. 19 
 
Derivatisation of chiral amino acids with chiral isocyanantes and isothiocyanates to give 
diastereomeric carbamates and thiourea derivatives is not carried out very often due to 
their requiring relatively high temperatures and longer reaction times than other CDAs.18 
 
Marfey´s reagent (1-fluoro-2,4-dinitrophenyl-5-L-alanine amide), widely used for the N-
derivatisation of amino acids, is a chiral derivative of 1-fluoro-2,4-dinitrobenzene. In ad-
dition to high yields of the resulting diastereomers, the application of Marfey´s reagent 
leads to products that are easily detectable with UV. 
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After derivatisation with FDAA (L enantiomer) and separation of the resulting di-
astereomers on RP-HPLC, the original L amino acid is often eluted prior to its D enanti-
omer. 
 
To enhance selectivity and to improve the predictabilities of the elution order, several 
variants of Marfey´s reagent were created by replacing Ala with other chiral entities 
such as valine or leucine (Figure 10)20: 
 
 
FDAA: R = CH3 
 
FDVA: R = CH(CH3)2 
FDPA: R = CH2-Ph 
FDIA: R = CH(CH3)CH2CH3 
FDLA: R = CH2CH(CH3)2 
 
D-FDAA 
  
Fig. 10: Variations of Marfey´s reagent (adapted from Ref. 20) 
 
 
Scientists also modified the aromatic group and replaced it with other chromophoric 
substituents. 
 
OPA and chiral thiols (N-acetyl-D-penicillamine, N-protected cysteine) are routinely 
used to derivatise chiral primary amino acids to yield highly fluorescent diastereomeric 
isoindol derivatives. 
 
Indirect enantioseparation of chiral amino acids can also be achieved by gas chroma-
tography. Due to its good separation performance, GC is a particularly interesting tool 
for analytical chemists. However, in order to analyse polar compounds such as amino 
acids by GC, they need to be derivatised to become less polar and more volatile. There-
fore, several methods for derivatisation of amino acids to give volatile diastereomers 
have been reported, e.g. in 2008 by Bertrand et al.21. It is based on ethyl chloroformate 
and 2-chloropropanol and the resulting diastereomers can be separated on an achiral 
gas chromatography column. 
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3.2) Direct Separation of Amino Acids and Peptides 
 
The direct approach to enantioseparation of amino acids and peptides is usually real-
ised in a separation of underivatised compounds on chiral stationary phases (3.2.1). 
However, in order to perform chiral GC or to separate the enantiomers of originally zwit-
terionic (amphoteric) compounds on chiral anion or cation exchangers, derivatisation 
with an achiral reagent may be required (3.2.2 and 3.2.3) 
 
 3.2.1) Chiral Liquid Chromatography 
 
As indicated in section 2.2, the separation of enantiomers with chiral stationary phases 
is by far the most commonly used chiral separation technique today. 
Chiral stationary phases for liquid chromatography may have the selector immobilised 
onto the silica surface (mostly employing a covalent linkage) or the stationary phase 
itself may be chiral (chiral monolithic columns). Sometimes, chiral molecularly imprinted 
polymers are employed. 
 
a) CSPs Based on Macrocyclic Antibiotics 
 
Macrocyclic glycopeptide antibiotics were first introduced by Armstrong in 1994.22 The 
most important chiral selectors based on macrocyclic antibiotics are vancomycin, tei-
coplanin and ristocetin A (Figure 11), which are fermentation products of fungi. Their 
biological activity is based on their affinity towards the D-Ala-D-Ala moieties of the cell 
walls of gram-positive bacteria.23 
Other antibiotics-based CSPs are based on ansamycines or aminoglycosides, although 
they are of far less importance than those mentioned above. 
 
Due to their structures, which feature a hydrophobic basket of macrocyclic rings linked 
by peptide and ether bonds and 2-6 carbohydrate moieties, glycopeptide antibiotics of-
fer various possible interactions with the selectand: ionic, H-bond, π−π interactions, di-
pole-dipole, hydrophobic and steric interactions contribute to retention and enantiose-
lectivity.  
Vancomycin, teicoplanin and ristocetin A are commercially available as ChirobioticTM 
CSPs with various binding chemistries. Today, their application for chiral separations is 
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common in many fields such as drug discovery or organic synthesis. They are the 
method of first choice when enantiomers of both free and N-protected amino acids and 
peptides are to be separated. 
For example, Berthod et al. reported the separation of 54 free amino acids (among them 
all proteinogenic amino acids) on a teicoplanin-based CSP employing an aqueous-
organic mobile phase. 24  
 
 
 
 
 
 
a 
 
b 
 
c 
 
Figure 11 (continued): Macrocyclic glycopeptide antibiotics as chiral selectors for 
HPLC. a Vancomycin b Ristocetin A c Teicoplanin 
 
 
 
Macrocyclic antibiotics offer several advantages, one of them being their applicability in 
various mobile phase modes. According to the mobile phase mode, the selectivities of 
the CSPs can vary, which is used in method development (Table 3.1).  
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Polar organic mode 
(methanol with or without acidic/basic 
modifier) 
ionic interaction 
hydrogen bonding 
steric interaction 
Reversed phase 
(buffers) 
ionic interaction 
hydrophobic inclusion 
hydrogen bonding 
steric interaction 
Normal phase hydrogen bonding 
p-p interaction 
dipole stackig 
steric interaction 
Table 3.1: Possible retention mechanisms for three mobile phase compositions on 
glycopeptide CSPs. (adapted from reference 23) 
 
 
Enantioselectivity can often be predicted for compounds with similar structural features 
– if one compound is separable on a certain CSP with a certain mobile phase then oth-
ers with the same functional groups attached to the steric center will most likely be 
separable with the same system. 
Macrocyclic antibiotics are highly selective for D-Ala-D-Ala peptide sequences. There-
fore, the L enantiomers of amino acids and peptides are often eluted previously to the D 
enantiomers. Especially high retention is to be expected for peptides with D amino acids 
at the C terminus.24 Elution order is normally the same on all 3 columns (V, R and T), so 
that column coupling is possible. In some cases though, elution order may be reversed 
between R and T and between R and V. 
On the other hand, the principle of complementary separation says that by switching 
from one ChirobioticTM column to another, selectivity can often be increased (but the 
reverse is also possible). 
 
Even though several protocols for method development for the separation of diverse 
racemates exist25, method development and optimisation on glycopeptide-based sta-
tionary phases may be very labour-intensive as there are so many parameters to be 
considered, among them the operating temperature and the type and amount of modi-
fier. Due to the large number of papers dealing with chiral separations on these station-
ary phases, literature research may be particularly time-consuming. 
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b) Molecular Imprinted Polymers 
 
MIPs are prepared by polymerisation of suitable functional monomers and cross-linkers 
in the presence of a molecular template. The latter is removed after polymerisation to 
leave a cavity which can incorporate molecules of the same structure as the template 
due to its shape. 
By using an enantiomerically pure template, enantioselective MIPs can be prepared for 
use in chromatographic applications (among others). 
 
Enantioseparation of N-protected amino acids and peptides on MIPs was reported as 
early as 1995.26 The predictable selectivites and elution orders are of great value, es-
pecially in preparative chromatography. Besides, the stability of the MIP stationary 
phases is superior to that of CSPs that have a selector immobilised onto solid support. 
However, the fact that a MIP CSP can only separate a very limited number of analytes 
(often only the one that was used as a template) and therefore have to be tailor-made 
for every application is a major drawback. 
Resolution and peak-shape are often poor, which is thought to be a result of limited 
mass transfer and heterogeneous binding sites.27 
Use of unsuitable mobile phases can cause swelling of the polymer, which further im-
pairs separation performance. 
 
 
3.2.2) Chiral Ligand Exchange Electrochromatography 
 
Electrochromatography is considered a hybrid of electrophoresis and chromatography. 
Depending on the stationary phase that is used (coating or monoliths), scientists can 
use it to perform ligand exchange experiments: 
 
Complexes consisting of metal ions such as Cu2+ and organic (often multidentate) 
ligands comprise the selectors in chiral ligand exchange chromatography. The chiral 
analytes can substitute one of the ligands of the complex and thereby form mixed cop-
per complexes as depicted in Figure 12. The diastereomeric complexes are of different 
stability and therefore suitable for enantiomer separation. Elution in electrochroma-
tography is achieved by applying a voltage to the capillary.  
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Figure 12: Principle of chiral electrochromatography (adapted from reference 28) 
 
 
 
Ligand exchange chromatography was initially performed on polymer resins containing 
amino acids complexed with metal ions.28 Later, the method was transformed to HPLC, 
with silica-based stationary phases onto which amino acids were immobilised. Cu2+ was 
used to facilitate complex-forming. 
The method was subsequently transferred to capillary electrochromatography (CEC) 
with monolithic phases and used for the enantioseparation of amino acids.29 
 
E. Pittler and her coworkers used silica-based stationary phases with covalently bonded 
or dynamically coated L-4-hydroxyproline as a chiral selector to separate amino acids.30 
They achieved baseline separation and acceptable resolution of phenylalanine and ty-
rosine isomers, although retention times were relatively long. (This can be overcome by 
increasing the temperature which might lead to formation of air bubbles in the system 
and an instable baseline). Some dipeptides such as Gly-Ala or Gly-Phe were also enan-
tioseparated, but with weaker results. 
 
Elution order can sometimes be reversed by switching from a column that has the se-
lector covalently linked to the silica to a column where the selector is dynamically 
coated onto the stationary phase. 
Mobile phases in CEC should contain metal ions to prevent column bleeding. Optimisa-
tion parameters should include temperature and mobile phase pH.  
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3.2.3) Chiral Gas Chromatography 
 
In addition to the applications presented above, direct chromatographic enantiosepara-
tion can also be facilitated with gas chromatography if the analytes are volatile enough 
or can be derivatised with a suitable non-chiral derivatising agent. 
 
Even though it is not quite as common as chiral (HP)LC, chiral GC columns are com-
mercially available from a variety of suppliers. 
They are usually based on various cyclodextrines or their derivatives (Astec CHIRAL-
DEXTM, Supelco DEXTM columns), which exhibit enantioselectivites based on the forma-
tion of inclusion complexes and polar interactions. 
The most widespread application of chiral GC makes use of the Chirasil-(L)-Val or -(D)-
Val columns, which has a chiral amino acid (derivative) immobilised onto the polysilox-
ane surface of the GC capillary. 
In 2009, H. Zahradnickova et al. reported the enantioseparation of a number of pro-
teinogenic amino acids on such a GC CSP. 31 However, the GC standard procedure of 
silylating polar groups is not a suitable derivatisation for chiral GC, so the scientists had 
to employ a technique which is significantly more laborious and time-consuming. 
This is a particularly important disadvantage of gas chromatography compared to chiral 
LC, especially if the analytes are as polar as amino acids and peptides. 
 
 
 
3.2.4) Chiral Ion Exchange Chromatography 
 
The underlying principle of ion exchange chromatography is, as the name suggests, the 
ionic interaction of a charged analyte with a stationary phase of the opposite charge. In 
chiral separations, these long-range interactions serve to bring the analyte into close 
contact with a chiral ion exchanging CSP, where enantioseparation is enhanced by non-
covalent interaction such as π−π stacking, hydrogen bonding between polar functional 
goups and steric interaction which in combination lead to the discrimination of one en-
antiomer. 
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At the beginning of section 3 it was mentioned that easy separation of zwitterionic com-
pounds into their enantiomers is not possible on chiral ion exchangers due to the pres-
ence of an intramolecular counterion in the selectand. 
It is possible to circumvent this by derivatising either the carboxylic (this is rarely done) 
or the amine functionality as it is routinely done in peptide synthesis. By creating an ei-
ther solely basic or solely acidic molecule, chiral ion exchange methods can be applied 
to amino acids and peptides. Besides, UV or fluorescence detection can be facilitated 
by introducing e.g. aromatic protective groups such as Fmoc or benzoyl. 
 
Figure 13 depicts N-protective groups often used for the derivatisation of amino acids 
and peptides. 
The carboxylic function can be derivatised by creating esters or amides. After the sepa-
ration, the protective groups can be removed by well-known protocols. 
 
 
 
Chemical Struc-
ture 
Chemical 
Name 
Abbr. Chemical 
Structure 
Chemical 
Name 
Abbr. 
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Ac 
 
 
 
 
3,5-
dinitrobenzoyl 
 
 
DNB 
 
 
 
 
 
benzoyl 
 
 
 
Bz 
 
 
 
 
 
2,4- 
dinitrophenyl 
 
 
 
DNP 
 
 
 
 
 
benzyloxy-
carbonyl 
 
 
Z 
(Cbz) 
  
 
9-fluorenyl-
methoxy-
carbonyl 
 
 
Fmoc 
 
 
 
 
t-Butyl-
oxy-
carbonyl 
 
 
Boc 
   
      
Fig. 13: Examples of N-protective groups for the derivatisation of amino acids. 
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Fig. 6a (p. 14) presents the structure of a commercially available chiral anion exchanger 
based on tert-butyl-cabamoylated quinine.  
When the CSP is operated under buffered hydro-organic conditions, the tertiary amine 
of the quinuclidine moiety is protonated (positively charged).32 Ionic interactions with the 
negatively charged acidic analytes are the basis of retention, but enantioselectivity is 
introduced by additional interactions such as hydrogen bonding, π−π interaction be-
tween aromatic groups and steric interactions. The carbamate substituent proved to be 
of special interest to the latter as bulky substituents resulted in especially high enanti-
oselectivities for N-protected amino acids.32 
Anion exchanging CSPs have also been employed successfully for the enantiosepara-
tion of N-protected peptides33 and other chiral acids such as sulfonic acids. 
 
Chiral cation exchangers are based on an acid function (e.g. a sulfonic acid, see Figure 
6, p. 14). To achieve enantiodiscrimination, a chiral center close to the acid moiety is 
crucial. CSPs like the one shown in Figure 5 offer additional functional moieties for π−π, 
hydrogen bond or van der Waals interactions to enhance selectivity. 
Chiral cation exchangers can serve for the enantioseparation of chiral amines such as 
Clenbuterol using nonaqueous polar organic mobile phases based on methanol or ace-
tonitrile. Acidic and basic mobile phase additives serve as co- and counterions which 
balance the strong ionic interactions and facilitate elution of the analytes.34 
 
 
 
3.3) Drawbacks of Conventional Separation Methods with Regard to Amino 
Acids and Peptides 
 
 
It was mentioned before that the indirect method of enantiomer separation has several 
drawbacks such as the need for an enantiomerically pure derivatisation reagent, the 
required presence of derivatisable groups in the selectand (no cause for concern with 
amino acids and peptides) or the possibly different dectector responses to the di-
astereomers which are formed in the process. 
Racemisation may occur under the derivatisation conditions and compromise the out-
come of the analysis. 
As mentioned in section 3.2.1, peptides (especially synthetic ones) are frequently hy-
drolised and the free amino acids are converted into diastereomeric derivatives with 
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appropriate CDAs to determine their amino acid composition. In the course of this proc-
ess, racemisation may occur. It is very intricate to differentiate between racemisation 
that occurred during peptide synthesis and racemisation during peptide hydrolysis or 
other stages of the synthesis (e.g. also during labelling). Sophisticated methods involv-
ing deuterated hydrolysis solvents and subsequent MS analysis may be required.18 
 
The direct approach to enantioseparation of chiral compounds can overcome several of 
the drawbacks attached to the indirect enantioseparation methods.  
However, the diverse techniques are still not perfectly suitable for amino acids and pep-
tides: 
Chiral GC, like GC in general, is best suited for apolar molecules. Polar compounds 
such as amino acids and peptides always have to be derivatised, which is often time-
consuming and can be a source of errors in an analytical method, if, for example, the 
derivatisation reaction is not quantitative. Often, not all amino acids can be derivatised 
without degradation. 
 
Chiral ligand exchange liquid chromatography requires a relatively sophisticated set-up 
and an experienced experimenter. Columns are not commercially available and the 
loadability is usually very low. Optimisation is time-consuming and retention times for 
amino acids are often unfavourably high. 
HPLC with enantioselective molecular imprinted polymers suffers from low loadabilities 
of the columns which, besides, have to be custom-made for every application. 
 
Today, the separation of amino acids and peptides is mainly carried out using CSPs 
based on glycopeptide antibiotics. The columns are commercially available. However, 
extensive optimisation may be required to solve a certain separation problem and the 
optimisation protocols usually rely on the use of at least 2 different columns. Elution or-
der reversal can only be achieved by switching to a column with a different CSP, which 
can result in changed separation characteristics. 
 
Zwitterionic compounds such as amino acids and peptides cannot be separated on 
chiral anion exchangers due to the presence of an intramolecular counterion in the se-
lectand. Achiral derivatisation of the N terminus of the analyte results in chiral acids 
which can be separated on cinchona-based chiral anion exchangers. 
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However, it is preferable to separate analytes without the need for a derivatisation reac-
tion, which always bears the risk of introducing errors into the analysis. 
 
 
4.) Zwitterionic chiral stationary phases (ZWIX CSPs) 
 
To overcome the limitations of enantioseparation of zwitterionic compounds on cation 
and anion exchanging CSPs, a novel type of zwitterionic chiral stationary phases was 
introduced by Professor Lindner´s research group in 2008.35 
 
Zwitterionic selectors for HPLC were prepared by fusing weak anion exchanging sites 
(WAX) based on cinchona alkaloids and sulfonic acids as strong cation exchanging 
sites (SCX), zwitterionic selectors for HPLC were prepared (Figure 14). 
 
 
 
 
Fig. 14: Zwitterionic chiral stationary phases (ZWIX CSPs) for HPLC enantiosepara-
tion (from reference 35). 
 
 
 
The resulting ZWIX CSPs combined the applicability of WAX CSPs for chiral acids and 
of SCX CSPs for chiral bases and, in addition, offered the possibility to separate enanti-
omers of amphoteric compounds. 
ZWIX CSPs based on cinchona alkaloids and sulfonic acids are operated in polar-
organic mobile phases with acidic and basic additives (typically in a 2:1 ratio), which 
modulate elution. 
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4.1) Separation of Acidic and Basic Analytes on ZWIX CSPs  
 
As indicated above, the ability of the WAX site to enantioseparate chiral acids is pre-
served in the novel ZWIX CSPs, with the added benefit of reduced retention times com-
pared to the underlying anion exchanger: the AX site in the selectors is a carboxylic 
(weaker) or sulfonic (stronger) acid which acts as an intramolecular counterion (IMCI) to 
the analyte. Retention can be further adjusted by the type and concentration of the 
acidic counterion in the mobile phase. 
By using quinine and its pseudo-enantiomer quinidine as chiral scaffolds for ion ex-
changers, it is possible to reverse the elution order of the analyte enantiomers34, which 
was found to be also true for the zwitterionic CSPs. This means that a chiral SCX site 
attached to the C-9 position (CSPs 3 and 4) is not predominant the enantiorecognition. 
In these systems, the latter is obviously determinded by the QN/QD-derived chiral scaf-
fold. 
 
The scientists also investigated the separation of chiral amines (bases) on the ZWIX 
CSPs depicted in Figure 14. ZWIX CSPs with a chiral cation exchanging site were able 
to separate the enantiomers of the drugs tested with significantly shorter retention times 
than on a SCX CSP, which was ascribed to the IMCI activity of the protonated quinucli-
dine moiety.  
From their results, the scientists concluded that the presence of a stereogenic center in 
the SCX site of the ZWIX selector is not necessary to achieve enantioseparation of 
chiral bases such as Mefloquine, but that it is highly beneficial. 
Elution orders can be reversed by switching from quinine to quinidine-based CSPs and 
also (for some analytes) by employing QN-based ZWIX CSPs with opposite configura-
tion of their SCX sites only. 
 
 
 4.2) Separation of Zwitterionic Analytes on ZWIX CSPs 
 
In their 2008 publication, Hoffmann et al. enantioseparated a large set of chiral zwitteri-
onic compounds such as amino acids and mixed dipeptides and established that the 
retention mechanism of zwitterionic compounds on ZWIX CSPs is based on simultane-
ous double ion pairing.35 
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The ZWIX CSPs that were evaluated showed different enantioselectivities towards 
groups of structurally similar analytes. With amphoteric analytes, the stronger sulfonic 
acid moiety led to higher retention factors than the weaker carboxylic acid due to a 
stronger SO-SA interaction. 
Apparently, elution orders for amphoteric analytes are determined mainly by the cin-
chona alkaloid scaffold, as they were found to be reversed on quinine and quinidine-
based ZWIX CSPs. 
 
 
 
 
Obviously, this type of CSPs presents a particularly interesting approach to the enantio-
separation of amino acids and peptides with all the benefits of direct enantioseparation 
techniques in HPLC. 
The aim of the present work was to prepare a series of three ZWIX CSPs with homolo-
gous SCX sites based on CSP 1 from Figure 14 (so-called Tau-QN, from the underlying 
taurine and quinine building blocks) and to evaluate the ZWIX CSPs for their enantio-
separation capabilities towards N-protected amino acids, free amino acids and peptides. 
Besides, their quinidine-based pseudo-enantiomers were to be synthesised, evaluated 
in the same way and compared to the quinine-based CSPs. 
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Experimental – Materials and Methods 
 
1) Materials 
 
1.1) Syntheses 
 
Syntheses procedures for the individual selectors are described in detail in the following 
chapter. 
 
Synthesis reagents were of reagent grade or higher purity and were purchased from 
Sigma-Aldrich (Vienna, Austria) unless stated otherwise. They were used without further 
purification. 
All reaction steps were performed under nitrogen and with oven-dried glassware. 
Technical Grade solvents (dichloromethane, ethylacetate, methanol, acetone, toluene) 
were purchased from VWR (via Merck, Darmstadt, Germany). 
HPLC grade solvents were from Sigma-Aldrich (acetone, water), Fluka (dichloro-
methane, via Sigma-Aldrich Austria), VWR (HiPerSolv methanol) and Carl Roth GmbH 
(n-heptane). 
 
For purification of synthesis products by column chromatography, Kieselgel 60 (40-63 
µm) was purchased from Merck (Darmstadt, Germany). 
 
Quinine and quinidine were purchased from Buchler (Braunschweig, Germany). 
 
Aminomethanesulfonic acid and taurine were from Sigma-Aldrich Austria and EGA 
Chemie Gesellschaft (Steinheim, Germany), respectively. 
 
1,3-Propanesultone and 1,4-butanesultone were purchased from Sigma-Aldrich and 
from Tokyo Chemical Industries (via TCI Deutschland, Eschborn, Germany). 
7N solutions of NH3 in methanol were from Sigma Aldrich Austria and Fisher Scientific 
(Schwerte, Germany). 
 
AIBN was purchased from Merck (Darmstadt, Germany). 
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N,N-Diethyl trimethylsilylamine was purchased from Bucher via Merck (Darmstadt, Ger-
many). 
N,N-Diisopropylethylamine and triethylamine were from Fluka via Sigma-Aldrich Austria. 
 
Silica gel for selector immobilisation (Daisogel 120-5P, 5µm particles, pore diameter 
120 Å) was purchased from Daiso Co., Ltd., Düsseldorf, Germany and mercaptopropyl-
modified in-house. 
 
1.2) Analyses 
 
NMR solvents were purchased from Deutero (Kastellaun, Germany). 
 
HPLC grade solvents (water, acetone) were purchased from Sigma-Aldrich (Vienna, 
Austria) and VWR (HiPerSolv methanol). 
 
Mobile phase additives (diethylamine, formic acid, ammonium acetate, formic acid, ace-
tic acid) were purchased from Fluka and Sigma-Aldrich. 
 
The chiral zwitterionic analytes and acidic drugs used for the evaluation of the ZWIX 
CSPs were either commercially available or gifts from research partners of our group. 
Protected amino acids had been synthesised in-house according to established proto-
cols. 
Peptide enantiomers were either commercially available from Sigma-Aldrich and 
Bachem (Weil am Rhein, Germany) or custom-synthesised by Genecust Europe (Dude-
lange, Luxembourg). 
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2) Methods 
 
2.1) Instrumentation 
 
Thin layer chromatography of synthesis products was performed on Kieselgel 60 F254 
TLC plates (Merck, Darmstadt, Germany) with UV detection at 254 nm in a cabinet from 
Camag (Berlin, Germany). 
 
NMR analyses were carried out on a Bruker DRX 400 MHz NMR spectrometer. Spectra 
were recorded in D2O, MeOH-d4 and CDCl3 (see individual spectra). Chemical shifts are 
stated in ppm (parts per million) with tetramethylsilane as internal standard. Solvent sig-
nals were used as reference signals. NMR spectra were processed with SpinWorks 
2.2.5. 
 
Mass Spectrometry experiments were performed on a PE Sciex API 365 triple-
quadrupol mass spectrometer equipped with an electrospray source and an Agilent 
1100 Series CL/MSD Trap ion-trap MS system. 
 
Elemental Analysis (CHNS) of immobilised selector was performed on an EA 1108 
CHNS-O Element Analyser (Carlo Erba, now Thermo Scientific, Germany) and selector 
coverage of the silica was calculated from the nitrogen content. 
 
HPLC experiments were performed on an Agilent 1100 HPLC system with MWD (multi-
ple wavelength detector) and an Agilent 1200 HPLC system (Agilent Technologies, 
Waldbronn, Germany), equipped with a DAD (diode array detector).  
Detection was at 254 nm for UV active analytes. 
Analytes with low or no absorption at 254 nm and peptides were detected with a Corona 
Charged Aerosol Detector (ESA Biosciences, Inc., Chelmsford, MA, USA). 
 
Methanol (50 mmol/L formic acid and 25 mmol/L diethylamine as additives) was used 
as the standard mobile phase - it had previously been established as a particularly ver-
satile mobile phase for cinchona-based ZWIX applications. 
For the experiments with a mixture of water and methanol as mobile phase, the solvents 
were mixed previously and allowed to cool to ambient temperature. After the addition of 
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25 mmol/L of diethylamine, apparent pH was set to 5,4 with formic acid (pH meter 540 
GLP from WTW via Aigner-Unilab, Vienna, Austria). 
 
Mobile Phase flow rate was usually 1 mL/min and analysis was carried out at room tem-
perature (22°C) unless stated otherwise. 
 
Stainless steel HPLC columns (150 x 4 mm) for the preparation of ZWIX columns were 
from Bischoff and were slurry-packed in-house. Chirobiotic columns (Chirobiotic V, Chi-
robiotic TAG; column dimensions: 250 x 4,6 mm, 5 µ material) were purchased from 
Astec (via  Sigma-Aldrich, Vienna, Austria). 
Void volumes of the columns were determined by injection of 10-50 µL of a 1:9 solution 
of acetone in MeOH. 
 
HPLC samples were prepared by dissolution of the analytes in either methanol or a mix-
ture of water and methanol (1:1, v/v) at a concentration of 1 mg/mL. 10 µL of these solu-
tions were injected into the HPLC system. 
Elution orders were determined by injection of a single enantiomer of the analyte if 
available. 
 
Data acquisition was achieved with Agilent ChemStation Software and Evaluation of the 
Data was carried out with Microsoft Excel. 
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2.2) ZWIX Selector Syntheses 
 
2.2.1) Tau-QN and Tau-QD 
 
 
Fig. 1: Taurine (2-aminoethanesulfonic acid) 
 
The synthesis concept of the taurine selectors was in accordance with Figure 2: 
 
 
 
Fig. 2:  Synthetic route from quinine to ZWIX CSP 1. Conditions: a 4-nitrophenyl 
chloroformate, toluenedest, r.t., 24 hrs, b taurine, BSA, DCMHPLC, reflux, 24 hrs, c 
AIBN, mercaptopropylsilane-modified silica gel, MeOHHPLC, reflux, 5 hrs 
 
 
Quinine (1) and quinidine, respectively, were converted into their activated ester hydro-
chlorides 2 by addition of an equimolar amount of 4-nitrophenyl chloroformate in tolu-
ene. The reaction mixture was refluxed for 24 hrs and the activated ester was obtained 
by filtration (a). 
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Finely ground taurine (4) was silylated with BSA in dried boiling dichloromethane and 
converted into tau-QN and tau-QD selectors 3 by addition of equimolar amounts of the 
respective activated esters of quinine and quinidine (b). 
After quenching of the reaction by addition of methanol, the selectors were purified by 
column chromatography with a stationary phase of 30 g silica for every g of theoretical 
yield. Apolar nitrophenol was eluted with DCM/MeOH 9:1 (v/v), and then the mobile 
phase was changed to DCM/MeOH 1:1 to facilitate elution of the polar product. The 
fractions containing product (control: TLC with DCM/MeOH 9:1) were pooled, solvent 
removed by evaporation and the product was dried in vacuum. 
ESI-MS (positive and negative mode) and NMR analysis were employed for characteri-
sation. 
 
N-[[[(8S, 9R)-6´-methoxycinchonan-9-yl]oxy]carbonyl]-aminoethanesulfonic acid 
 (Tau-QN): 
86%, light yellow crystals. 1H NMR [CD3OD]: δ = 8.73 (d, 1H), 8.00 (d, 1H), 7.64 (d, 1H), 
7.50 (s, 1H), 7.48 (d, 1H), 6.94 (s, 1H), 5.78 (m, 1H), 5.14 (d, 1H), 5.05 (d, 1H), 4.05 (s, 
3H), 3.87-3.74 (m, 2H), 3.65 (m, 2H), 3.50 (m, 1H), 3.37 (m, 2H), 3.01 (m, 2H), 2.84 (m, 
1H), 2.30-2.19 (m, 2H), 2.13 (m, 1H), 1.99 (m, 1H), 1.75 (m, 1H).  
13C NMR: δ = 160.5 (Car), 155.9 (C=O), 147.8 (CarH), 144.4 (Car), 143.6 (Car), 138.9 
(CH=), 131.4 (CarH), 127.4 (CarH), 124.3 (CarH), 119.5 (CarH), 117.4 (CH2=), 102.3 
(CarH), 71.1 (CH), 60.0 (CH), 57.1 (OMe), 55.8 (CH2), 51.5 (CH2), 45.5 (CH2), 38.4 
(CH2), 38.3 (CH), 28.2 (CH), 25.0 (CH2), 20.7 (CH2). 
MS (ESI, positive): 476.4 [M+H]+, 498.4 [M+Na]+. MS (ESI, negative): 474.2 [M-H]¯. 
 
 
N-[[[(8R, 9S)-6´-methoxycinchonan-9-yl]oxy]carbonyl]-aminoethanesulfonic acid 
 (Tau-QD): 
58%, yellow crystals. 1H NMR [CD3OD]: δ = 8.79 (d, 1H), 7.96 (d, 1H), 7.78 (d, 1H), 
7.56-7.50 (m, 2H), 7.11 (s, 1H), 6.14 (m, 1H), 5.33-5.24 (m, 2H), 4.01 (s, 3H), 3.87 (m, 
1H), 3.65-3.51 (m, 5H), 3.37 (m, 1H), 3.02 (m, 2H), 2.77 (m, 1H), 2.42 (m, 1H), 2.06 (m, 
1H), 2.02-1.83 (m, 2H), 1.47 (m, 1H).  
13C NMR: δ = 161.2 (Car), 155.7 (C=O), 146.8 (Car), 145.8 (CarH), 141.2 (Car), 137.9 
(CH=), 128.8 (CarH), 127.9 (Car), 126.1 (CarH), 120.1 (CarH), 118.4 (CH2=), 102.6 
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(CarH), 71.4 (CH), 59.8 (CH), 57.4 (OMe), 51.5 (CH2), 51.0 (CH2), 50.1 (CH2), 38.5 
(CH2), 38.2 (CH), 28.7 (CH), 23.7 (CH2), 20.4 (CH2). 
MS (ESI, positive): 476.2 [M+H]+, 498.2 [M+Na]+, 951.4 [2M+H]+, 973.4 [2M+Na]+. 
 
For immobilisation, the Tau-QN selector was added to a suspension of 3 µm mercapto-
propyl-modified silica gel in methanol (1 mmol SO, 3 g silica). By refluxing of the reac-
tion mixture with the radical initiator AIBN (40 mg of initiator per mmol SO) for 5 hrs, the 
selector was covalently bound to the surface (Figure 2, c). 
 
After drying the CSP was subjected to CHNS elemental analysis which gave a surface 
coverage of 224 µmol selector/g silica.  
Tau-QD was not immobilised as two CSPs with the selector existed already. 
 
CSP 1 
 
QN-based 
CSP 2 
QD-based 
Fig. 3: Tau-QN and Tau-QD CSPs 
 
For the evaluation and comparative experiments, Tau-QN and Tau-QD columns with 5 
µm material that had been prepared by members of our group were used. 
 
 
2.2.2) Homotau-QN and Homotau-QD 
 
For the synthesis of the homotaurine-selectors homotau-QN and homotau-QD, homo-
taurine (6) was prepared by ring opening of 1,3-propanesultone (5) with ammonia36 ac-
cording to Figure 4: 
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Fig. 4: Preparation of homotaurine (3-aminopropanesulfonic acid, 6) by ring 
opening of 1,3-propanesultone (5) Conditions: a: MeOH, NH3, -21°C to r.t, 18 
hrs. 
 
 
1,3-propanesultone (5) was filled into a reaction flask and cooled with a mixture of ice 
and NaCl. A three-fold excess of NH3 (as a 7N methanolic solution) was added slowly, 
while the reaction mixture was stirred continuously. 
After completion of the addition, the mixture was cooled for another two hours and then 
the ice was allowed to melt and the solution was stirred overnight. 
Homotaurine was obtained as a white precipitate which can be recrystallised from a wa-
ter/ethanol (1:1 v/v) mixture. 
Conversion was always quantitative throughout an upscaling process from 4 to 200 
mmol. 
 
Homotau-QN and Homotau-QD selectors were prepared as depicted in Figure 5 (the 
procedure is analogous to the synthesis described in detail in section 2.2.1 for Tau-QN 
and Tau-QD).  
Homotaurine from the ring opening was finely ground and silylated with BSA in dried 
boiling dichloromethane. Conversion with the activated esters of quinine and quinidine, 
respectively, was carried out in toluene. Selector synthesis was quenched by addition of 
methanol and the concentrated mixture was subjected to column chromatography on 30 
g of silica per g of theoretical yield to remove nitrophenol (mobile phase: DCM/MeOH 
9:1 v/v). The product was eluted with DCM/MeOH 1:1 (monitoring by TLC), dried in vac-
uum and characterised by MS and NMR analysis. 
The respective selectors, Homotau-QN and Homotau-QD, were immobilised onto mer-
capto-modified silica by radical addition (AIBN) in methanol to give CSPs 3 and 4 (Fig. 
6) 
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Fig. 5: Synthetic route from quinine to ZWIX CSP 3. Conditions: a 4-nitrophenyl 
chloroformate, toluenedest, r.t., 24 hrs, b homotaurine, BSA, DCMHPLC, reflux, 24 hrs, 
c AIBN, mercaptopropylsilane-modified silica gel, MeOHHPLC, reflux, 5 hrs 
 
 
CSP 3 
 
 
CSP 4 
 
 
Fig. 6: Homotau-QN (CSP 3) and Homotau-QD (CSP 4) 
 
 
N-[[[(8S, 9R)-6´-methoxycinchonan-9-yl]oxy]carbonyl]-aminopropanesulfonic acid 
 (Homotau-QN): 
70%, light yellow crystals.  
MS (ESI, negative): 488.0 [M-H]-; MS (ESI, positive): 490,2 [M+H]+ 
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N-[[[(8R, 9S)-6´-methoxycinchonan-9-yl]oxy]carbonyl]-aminopropanesulfonic acid 
 (Homotau-QD): 
50%, yellow crystals. 1H NMR [CD3OD]: δ = 8.79 (d, 1H), 7.88 (d, 1H), 7.81 (d, 1H), 
7.55 (m, 2H), 7.00 (s, 1H), 6.11-6.0 (m, 1H), 5.2-5.1 (m, 2H), 3.94 (s, 3H), 3.76 (m, 1H),  
3.49 (m, 3H), 3.27 (s, 1H), 3.13 (m, 2H), 2.84-2.61 (m, 3H), 2.31 (m, 1H), 2.08-1.70 (m, 
5H), 1.36 (m, 1H). 
MS (ESI, negative): 488.1 [M-H]- 
 
CHNS elemental analysis gave a surface coverage of 280 µmol selector/g silica for 
CSP 3 and 188 µmol selector/g silica for CSP 4. 
 
 
2.2.3) Homohomotau-QN and Homohomotau-QD 
 
Synthesis procedures for Homohomotau-QN and Homohomotau-QD were carried out in 
analogy to those described in detail above. 
 
Homohomotaurine (9) was prepared from commercially available 1,4-butanesultone by 
ring opening with NH3 (36,37) with a yield of over 85% and recrystallised from wa-
ter/ethanol (1:1 v/v) (Figure 7). 
 
 
Fig. 7: Preparation of Homohomotaurine (4-aminobutanesulfonic acid, 9) by 
ring opening of 1,4-butanesultone (8). Conditions: a: MeOH, NH3, -21°C to r.t, 
18 hrs. 
 
 
1,4-Butanesultone was cooled with ice/NaCl (3:1) and a three-fold excess of NH3 
(methanolic solution) was added slowly. The ice was allowed to melt after ca. 2 hrs of 
stirring, and stirring was continued overnight. Homohomotaurine, which precipitated 
from the solution, was obtained by filtration and dried in vacuum.  
The aminobutanesulfonic acid was finely ground and silylated with BSA in dried boiling 
dichloromethane for 24 hrs (Figure 8). 
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Reaction of the silylated homohomotaurine with the activated esters of quinine and 
quinidine (2) gave the homohomotau-QN and homohomotau-QD selectors (10). After 
purification of the selectors by column chromatography (30 g of silica for every g of 
theoretical yield, mobile phase DCM/MeOH 9:1 (v/v) for the elution of nitrophenol and 
DCM/MeOH 1:1 for the elution of the product), they were characterised by MS and NMR 
analysis. 
 
 
 
Fig. 8. Synthetic route from quinine to ZWIX CSP 5. Conditions: a 4-nitro-phenyl 
chloroformate, toluenedest, r.t., 24 hrs, b homohomotaurine, BSA, DCMHPLC, reflux, 24 
hrs, c AIBN, mercaptopropylsilane-modified silica gel, MeOHHPLC, reflux, 5 hrs 
 
 
 
N-[[[(8S, 9R)-6´-methoxycinchonan-9-yl]oxy]carbonyl]-aminobutanesulfonic acid 
(Homohomotau-QN): 
40%, light yellow crystals. 1H NMR [CD3OD]: δ = 7.88 (d, 1H), 7.48 (d, 1H), 7.39 (m, 
2H), 6.69 (s, 1H), 5.74-5.62 (m, 1H), 5.04-4.98 (d, 1H), 4.95-4.90 (d, 1H), 3.93 (s, 3H), 
3.62-3.57 (s, 1H), 3.54-3.48 (s, 1H), 3.15-3,04 (m, 3H), 3.04-2.98 (m, 1H), 2.87-2.83 (d, 
1H), 2.78-2.68 (m, 3H), 2.61 (s, 1H), 2.10-1.90 (m, 3H), 1.83-1.48 (m, 6H). 
MS (ESI, negative): 502,8 [M-H]- 
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N-[[[(8R, 9S)-6´-methoxycinchonan-9-yl]oxy]carbonyl]-aminobutanesulfonic acid 
(Homohomotau-QD): 
20%, yellow crystals.  
MS (ESI, negative): 502,6 [M-H]- 
 
Homohomotau-QN and homohomotau-QD were immobilised onto mercaptopropylsilyl 
modified silica gel in a radical addition reaction with AIBN as described in 2.2.1 for the 
taurine selectors. 
 
CHNS elemental analysis gave a surface coverage of 254 µmol selector/g silica for 
CSP 5 and 187 µmol selector/g silica for CSP 6. 
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RESULTS & DISCUSSION 
 
A) Synthesis of ZWIX Selectors 
 
1) Standard Procedure & ZWIX CSP Characteristics 
 
In the course of this work, 3 quinine-based zwitterionic CSPs with homologous aminoal-
kanesulfonic acids as SCX part and their pseudo-enantiomeric quinidine-based ana-
logues were synthesised. 
 
It has been shown before that quinine ((8α, 9R)-6´-methoxy-Cinchonan-9-ol, Figure 1a) 
and its pseudo-enantiomer quinidine ((9S)-6´-methoxy-Chinconan-9-ol, Figure 1b) as 
chiral backbones for CSPs can be very useful as they usually achieve comparable se-
lectivity, but reversed elution order.34 This is particularly important when dealing with 
enantiomeric impurities. 
In synthesising and evaluating both pseudo-enantiomeric forms of each CSP, this be-
haviour was to be further investigated. 
 
 
 
 
1a 
 
 
1b 
 
Fig. 1: Pseudo-enantiomeric cinchona alkaloids quinine (1a) and quinidine (1b) which 
form the chiral backbone of ZWIX selectors. 
 
 
Some ZWIX CSPs included in this investigation (Tau-QN and Tau-QD) have been syn-
thesised and evaluated before 35 and showed a great potential for the separation of ion-
isable, especially zwitterionic, chiral compounds. 
It was to be expected that CSPs including homologous acids, namely aminomethane-
sulfonic acid (AMSA), aminopropanesulfonic acid (homotaurine), and aminobutanesul-
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fonic acid (homohomotaurine), as their cation exchanger sites would be similarly useful 
in chiral separations of zwitterionic compounds. 
The “distance” between the anion and cation exchanger sites of the selector – summa-
rising all directly associated conformational variabilities of the zwitterionic selectors and 
thus their special arrangements - is, of course, crucial to the enantioseparation of zwit-
terionic analytes. This aspect was going to be investigated by the separation of homolo-
gous peptide enantiomers on the homologous CSPs. 
 
It has been mentioned that some of the CSPs have already been synthesised before, 
whereas others (those featuring homotaurine and homohomotaurine as the cation ex-
changing sites) were novel. 
Syntheses of CSPs 3-6 included a ring opening reaction of 1,3-propanesultone and 1,4-
butanesultone to yield homotaurine and homohomotaurine, as those compounds were 
not easily commercially available. 
Ring opening was achieved by treatment of the respective sultone with a methanolic 
solution of ammonia at reduced temperature (for details, see synthesis of the homotau 
and homohomotau selectors). These reactions yielded the internal salts of the aminoal-
kane sulfonic acids. 
 
Table 1.1 shows the individual CSPs with their full and short names: 
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CSP  Alkaloid 
(WAX 
part) 
Sulfonic Acid 
(SCX part) 
Full Name Short 
Name 
 
CSP 1 
 
 
quinine 
 
taurine 
 
taurine-quinine 
 
Tau-QN 
 
CSP 2 
 
 
quinidine 
 
taurine 
 
taurine-quinidine 
 
Tau-QD 
 
CSP 3 
 
 
quinine 
 
homotaurine 
 
homotaurine-quinine 
 
Htau-QN 
 
CSP 4 
 
 
quinidine 
 
homotaurine 
 
homotaurine-quinidine 
 
Htau-QD 
 
CSP 5 
 
 
quinine 
 
homohomotaurine 
 
homohomotaurine-
quinine 
 
Hhtau-QN 
 
CSP 6 
 
 
quinidine 
 
homohomotaurine 
 
homohomotaurine-
quinidine 
 
Hhtau-QD 
 
CSP 7* 
 
 
quinine 
 
aminomethanesulfonic 
acid 
 
aminomethanesulfonic 
acid-quinine 
 
AMSA-QN 
Table 1.1: Zwitterionic chiral stationary phases based on taurine-homologues and 
cinchona alkaloids (* CSP 7: not realised) 
 
 
The selector syntheses were carried out according to Figure 2 (for details, see Experi-
mental 2.2.1). 
 
Quinine and quinidine (1), respectively, were converted into their activated ester hydro-
chlorides (QN-AE/QD-AE, 2) by addition of 4-nitrophenyl chloroformate (a). 
The products are prone to hydrolysis and therefore have to be stored under nitrogen. 
The aminoalkane sulfonic acid was silylated with N,O-bis(trimethylsilyl)acetamide (BSA) 
to increase its solubility in apolar dichloromethane (DCM) which was used as solvent for 
the subsequent conversion of the active ester and the acid into the zwitterionic selector 
3 (b). 
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Fig. 2: Synthetic route from quinine to ZWIX CSP 1. Conditions: a 4-nitrophenyl 
chloroformate, toluenedest, r.t., 24 hrs, b aminoalkanesulfonic acid, BSA, DCMHPLC, 
reflux, 24 hrs, c AIBN, mercaptopropylsilane-modified silica gel, MeOHHPLC, reflux, 5 
hrs. 
 
 
Completion of the silylation step (indicated by a clear solution of the aminoalkanesulfo-
nic acid in DCM) is crucial for an acceptable selector yield. 
After completion of the reaction, remaining activated ester was quenched with methanol 
and the product was purified by column chromatography to remove byproducts (nitro-
phenol and, most critically, polar acetamide from the silylation) and reagent residues. 
For selector immobilisation by radical addition, dried mercaptosilane-modified silica gel 
was suspended in methanol and, by means of the radical initiator AIBN, the selector 
was covalently bound to the silica surface as depicted in Figure 2 (c). 
In this step, particular attention has to be paid to the reaction conditions and the set-up 
of the apparatus because the radical initiator is only effective at temperatures above 
60°C and grinding of the stirrer against the glassware can impair immobilisation. 
 
Overall yields decreased from Tau- over Homotau- to Homohomotau-QN and QD selec-
tors and selector loadings varied from 150-280 µmol selector/g silica (Table 1.2). It is 
worth mentioning that generally, ionic selectors are more difficult to immobilise than 
non-charged ones. 
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CSP Number Short Name Selector Coverage 
(µmol SO/g silica) 
 
CSP 1 
 
 
tau-QN 
 
205 
 
CSP 2 
 
 
tau-QD 
 
150 
 
CSP 3 
 
 
htau-QN 
 
280 
 
CSP 4 
 
 
htau-QD 
 
188 
 
CSP 5 
 
 
hhtau-QN 
 
254 
 
CSP 6 
 
 
hhtau-QD 
 
187 
 
Table 1.2: Selector coverages of ZWIX CSPs used in this study. 
 
 
The selector loadings of the individual ZWIX CSPs are sufficient for chiral separation 
and for comparison of the separation capabilities of the various CSPs: Previous studies 
have established that (above a certain value) selector loading only affects retention, but 
not selectivity. 
 
2) Variation of Standard Synthesis Procedure 
 
The standard procedure for the synthesis of cinchona-based ZWIX selectors as de-
scribed above has been carried out numerous times, mostly with selector yields be-
tween 60-80%. Higher yields are needed in order to facilitate upscaling procedures. 
Therefore, a number of synthesis steps were systematically altered to achieve more 
satisfactory results: 
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2.1) Silylating Agent N,N-diethyltrimethylsilylamine 
 
It has been stated before that in order to achieve a high selector yield, the silylation of 
the aminoalkanesulfonic acid has to be quantitative. 
 
BSA has been found to be unsuitable for the silylation of AMSA (see 2.2.5). Therefore it 
is obvious that a silylating agent other than BSA has to be included in the attempts to 
improve the outcome of the tau-QN synthesis. N,N-diethyltrimethylsilylamine (11, Figure 
3) was the reagent of choice: 
 
 
Fig. 3: N,N-diethyltrimethylsilylamine 
(TMSDEA) 
 
 
Whereas BSA´s relatively polar silylation by-product acetamide turned out to be very 
difficult to remove from the selector, diethylamine, the by-product of TMSDEA, is very 
volatile.38 This was supposed to be beneficial to the time-and solvent consuming selec-
tor purification by column chromatography.  
There are many examples for successful silylation of acids and amino acids with 
TMSDEA but it was obviously unsuitable for the silylation of taurine: even though the 
silylation was continued for 48 hrs, the reaction mixture never turned clear. As men-
tioned above, this indicates that the silylation was not quantitative. 
 
 
2.2) Hünig´s Base (N,N-diisopropylethylamine) as HCl Scavenger 
 
 
Following the standard selector synthesis protocol as described in 2.2, the activated 
ester is added to the silylated aminoalkanesulfonic acid in its hydrochloride form. 
We can assume that the HCl will compromise the conversion of the AE into the ZWIX 
selector - at least to some extent – due to its ionic properties. 
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Converting the active ester into its free base before using it for the selector synthesis 
would be impractical due to its instability towards hydrolysis; therefore an HCl scaven-
ger was employed: 
 
N,N-diisopropylethylamine (Hünig´s base, 12, Figure 4) was added directly to the reac-
tion mixture in substoichiometric amount prior to the addition of the activated ester. 
 
 
Fig. 4: N,N-diisopropylethylamine 
(Hünig´s base) 
 
 
The rest of the procedure was carried out according to the established method. It turned 
out that Hünig´s base did not bring about the expected improvements in selector yield. 
 
2.3) Product Purification by Precipitation 
 
Although it is often the most suitable way to purify synthesis products, column chroma-
tography is known to affect adversely the yield of synthetic procedures. 
This holds true especially in the case of zwitterionic selector synthesis where, in order to 
separate the selector from the polar silylation by-product acetamide, only the main frac-
tions containing product can be used. 
Besides, column chromatography is very time-consuming and uses up large quantities 
of organic solvents. 
For these reasons, alternative purification routes were also included in the efforts to 
make the selector synthesis route suitable for up-scaling. 
 
Precipitation of products is often used in synthetic chemistry and was thought to be a 
suitable approach for the zwitterionic selector molecule as well. 
Solubility experiments were conducted with the components of the reaction mixture 
(namely quinine, activated ester, selector, acetamide, nitrophenol) and revealed that the 
selector was practically insoluble in ethyl acetate, whereas the most unwanted reaction 
by-product acetamide was readily dissolved in this medium. 
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Therefore, selector synthesis was carried out according to the standard protocol de-
scribed above, but instead of perfoming a separation of reaction products by chroma-
tography, the reaction mixture was left standing for several days. 
After completion of the reaction, the mixture was concentrated and the residue taken up 
in ethyl acetate. 
Insoluble components were filtrated off and the filtrate analysed by RP-HPLC with UV 
detection. The process was repeated twice, but separation of acetamide, selector and 
taurine was not satisfactory. 
 
2.4) One-pot Reaction 
 
In an attempt to reduce time and solvent consumption and thereby make the selector 
synthesis fit for upscaling, the reaction was carried out as a one-pot synthesis in a 
minimum of solvent (ca. 15 % of normal amount) with consecutive addition of taurine, 
activated ester and BSA. 
After stirring for 48 hrs, TLC showed product formation. 
Nevertheless, after column chromatography the yield was only 12%, which is signifi-
cantly lower than that achieved with the standard synthesis protocol and does not justify 
the reduction of solvent consumption. 
 
 
3) Unrealised Selector: AMSA-QN 
 
3.1) AMSA-QN Synthesis 
 
Synthesis of AMSA-QN was to be carried out in analogy to the selector syntheses de-
scribed above: 
Quinine activated ester (2) was prepared by reaction of the cinchona alkaloid with 4-
nitrophenyl chloroformate (Figure 5). 
AMSA (13, Figure 6) was finely ground and silylated with BSA, but, in contrast to the 
other aminoalkane sulfonic acids, silylation was not complete after 20 hrs, which was 
indicated by a cloudy (or, at another attempt, even dark brown) mixture instead of a 
clear solution in the reaction flask. 
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Fig. 5: Synthesis of AMSA-QN (unsuccessful). Conditions: a 4-nitrophenyl chlorofor-
mate, toluenedest, r.t., 24 hrs, b aminomethanesulfonic acid, BSA, DCMHPLC, reflux, 20 
hrs 
 
 
 
 
Fig. 6: Aminomethanesulfonic acid (AMSA) 
 
 
Suspicions that the subsequent conversion with the activated ester had not been suc-
cessful were confirmed by MS analysis where no molecule peak was found.  
 
The silylation step is known to be crucial to the outcome of the experiment and was 
therefore repeated with freshly purchased silylating agent and prolonged reaction time 
(48 hrs) but again, no product was formed according to TLC and MS analysis. 
It can be assumed that the silylation of AMSA with BSA is sterically hindered. Therefore, 
an alternative route to AMSA-QN had to be looked for. 
 
 
3.2) The Search for an Alternative Route to AMSA-QN 
 
3.2.1) O-iPr as Protective Group 
 
As steric hindrance was suspected to be reason for the failure of the standard synthesis 
procedure with aminomethanesulfonic acid, it was decided that an alternative reagent 
for the introduction of a protective group was to be employed. 
Based on 39 and 40, aminomethanesulfonic acid was supposed to react with triisopropyl 
orthoformate according to Figure 7: 
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Fig. 7: Introduction of protective group into aminomethanesulfonic acid with triiso-
propyl orthoformate (not successful). Conditions: a : CH(O-iPr)3, DCMHPLC, reflux, 36 
hrs 
 
 
Reaction control by TLC with permanganate coloring reagent showed that the derivati-
sation had not been successful. 
 
3.2.2) Silylation with Chlorotrimethylsilane 
 
According to 41 and 42, silyl protective groups can be introduced into amino acids with 
chlorotrimethylsilane. 
Therefore, AMSA was supposed to react with chlorotrimethylsilyl according to Figure 8: 
 
 
 
Fig. 8: Synthesis of AMSA-QN with chlorotrimethylsilane as silylating agent (not 
successful). Conditions: a (CH3)3SiCl, DCMHPLC (distilled over CaCl2), reflux (over-
night), b NEt3, QN-AE, r.t., 48 hrs c MeOH 
 
 
Even though TLC analyis before quenching (c) and during column chromatography puri-
fication suggested product formation, MS analysis proved that the synthesis had not 
been successful. 
 
Apparently, it is due to its small size that AMSA cannot be derivatised and converted 
into a cinchona-based sulfonic acid-type ZWIX selector by the selector synthesis proto-
cols that were used for its homologues taurine, homotaurine and homohomotaurine. 
 
Finding a synthetic route to AMSA-QN to complete the series of homologous ZWIX se-
lectors exceeds the scope of this work and may be the subject of further experiments. 
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B) CSP Evaluation 
 
In this chapter, the evaluation of the quinine- and quinidine-based zwitterionic selectors 
with a set of chiral acidic and zwitterionic analytes is discussed. 
Chromatographic parameters are compared for QN- and QD-based CSPs and for CSPs 
incorporing homologous sulfonic acid side chains. 
 
A separate section is dedicated to the enantioseparation of peptides on the ZWIX 
CSPs. 
Homologous all-L and all-D alanine and valine peptides and several mixed di- and 
tripeptides were analysed and the results are presented with reference to the separation 
of peptides on ChirobioticTM CSPs. 
The influence of the water content of the bulk solvent on peptide retention and separa-
tion on QN-based ZWIX CSPs was also investigated and the results are presented in 
the last section of this chapter. 
 
 
The following chromatographic parameters were determined to evaluate the perform-
ance of the individual CSPs: 
 
- Retention factors ki 
The retention factor is calculated from the void time of the column, t0, and the re-
tention time of the compound: 
0
0
t
ttk Ri
−= . 
In this study, k1 and k2 represent the retention factors of the first and second 
eluted enantiomers, respectively. 
ki reflects the strength of the interactions between stationary phase and selec-
tand: The stronger the interactions, the longer the retention time and the larger 
the retention factor. A chiral stationary phase is expected to interact differently 
with the two enantiomeric forms of an analyte and therefore lead to different re-
tention factors for the R and S enantiomer (amino acids and peptides: D and L 
enantiomers). 
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In ZWIX applications, the number of possible selector-selectand interactions (and 
hence, the retention time) is heavily dependent on the selector loading of the 
CSP (given as amount of selector/ g stationary phase or µmol selector / m2 of 
surface). 
Retention factors between 1 and 5 are most desirable for a chromatographic 
separation, because k values below 1 indicate weak selector-selectand interac-
tions while k values above 5 lead to impracticably long retention times. 
 
- Selectivity factors αij 
α values are descriptive of the separation capabilities of a stationary phase. They 
are calculated from the retention factors of the analytes: 
1
2
12 k
k=α , 
with k1 and k2 representing the retention factors of the first and second eluted 
enantiomers. 
A difference in the strength of the interactions between the stationary phase and 
the two analytes involved (here: the two enantiomeric forms of a chiral molecule) 
leads to different retention factors and, therefore, to a selectivity factor greater 
than 1. An α value of 1 means that there is no (enantio)selectivity of the CSP for 
this analyte. 
High selectivity factors are especially desirable for preparative applications or if 
one is dealing with unfavourable peak-shapes (e.g. tailing). 
 
To demonstrate enantioselectivity, we define an elution-order dependent selectiv-
ity factor αEO: 
D
L
EO k
k=α , with kL and kD being the respective retention factors of 
the L and D enantiomer. Here, α > 1 means that the D enantiomer is eluted first, 
while α < 1 means the L enantiomer is eluted first. α = 1 indicates that there is no 
enantioselectivity and both enantiomers have the same retention times. 
 
- Theoretical plate numbers Ni 
In chromatography, a theoretical plate (originally an expression from the theory of 
distillation) is a (virtual) section of the column in which equilibrium is established 
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between mobile and stationary phase. As the analyte travels through the system, 
this process occurs a number of times – referred to as theoretical plate number 
N. 
N can be calculated from the retention time of the analyte and the peak width at 
the base (w) or at half maximum (w0,5): 
2
5,0
2
54,516 ⎟⎟⎠
⎞
⎜⎜⎝
⎛=⎟⎠
⎞⎜⎝
⎛=
w
t
w
tN RR  
The theoretical plate number serves as a measure for the separation perform-
ance of a chromatographic system. 
The height of a theoretical plate is calculated from the plate number and the 
length of the chromatographic column. 
 
- Chromatographic resolution R 
While the selectivity factor reflects the chromatographic separation performance 
on the grounds of the phase system, the chromatographic resolution takes into 
account the number of theoretical plates (the efficiency) as well. 
2
2
1
1
4 k
kNR +⋅
−⋅= α
α . 
R is the basis for the optimisation of a chromatographic separation: α and k can 
be modified by mobile phase variation, N by changing the column length, the 
mobile phase flow rate or the particle size of the stationary phase.43 
 
 
1.) Comparison of Quinine- and Quinidine-Based ZWIX CSPs 
 
It has been stated before that quinine and quinidine-based selectors can act as pseudo-
enantiomers. As CSPs, they often show comparable enantioselectivities for individual 
analytes, but reversed elution order. 
Sets of acidic and zwitterionic analytes and peptides were enantioseparated on tau-QN, 
homotau-QN and homohomotau-QN and on their quinidine-based homologues to fur-
ther investigate the pseudo-enantiomeric nature of these zwitterionic selectors. 
The mobile phase employed was methanol with 50 mM formic acid and 25 mM diethyl-
amine, which corresponds to an apparent mobile phase pH of 5,4. 
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Elution of zwitterionic analytes was carried out in isocratic mode - the mobile phase ad-
ditives act as co- and counterions simultaneously and render gradient elution unneces-
sary. 
 
 
1.1) Acidic Analytes 
 
 
In addition to their obvious capacity for the enantioseparation of zwitterionic com-
pounds, the ZWIX CSPs presented here can also be employed for the enantiosepara-
tion of acids or bases. Compared to “classical” anion or cation exchangers, ZWIX CSPs 
have the advantage of reduced retention times due to the presence of a charge of the 
same name as the analyte´s on the selector, which is referred to as an intramolecular 
counterion (IMCI). 
N-protected amino acids with diverse protective groups comprise the largest part of 
acidic analytes. In addition, a chiral drug (Naproxen) and two chiral herbicides (dichlor-
prop and mecoprop) are included in the acidic analyte set (Figure 9). 
 
 
 
Amino Acid 
 
 
Symbol 
 
Structural Formula 
 
 
 
 
Fmoc-Phenylalanine 
 
 
 
 
Fmoc-Phe 
 
 
 
 
 
 
Fmoc-Serine 
 
 
 
Fmoc-Ser 
 
 
 
 
Fig. 9: Acidic analytes for the evaluation of zwitterionic chiral stationary 
phases 
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Benzyloxycarbonyl-
Phenylalanine 
 
 
 
Z-Phe 
 
 
 
 
 
 
Benzyloxycarbonyl-β-
Phenylalanine 
 
 
 
 
Z-β -Phe 
 
 
 
 
 
 
 
Dinitrobenzoyl-
Phenylalanine 
 
 
 
 
DNB-Phe 
 
 
 
 
 
DNB-Glutamic Acid 
 
 
DNB-Glu 
 
 
 
 
 
DNB-Aspartic Acid 
 
 
DNB-Asp 
 
 
 
 
 
N-Acetyltryptophane 
 
 
Ac-Trp 
 
 
 
 
 
Dinitrophenyl-Glutamic 
acid 
 
 
DNP-Glu 
 
 
Fig. 9 (continued): Acidic analytes for the evaluation of zwitterionic chiral 
stationary phases. 
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Dinitrophenyl-Aspartic 
acid 
 
 
DNP-Asp 
 
 
 
 
Dinitrophenyl-
Phenylalanine 
 
 
DNP-Phe 
 
 
 
 
2-(2,4-dichlorophenoxy) 
propionic acid 
 
 
Dichlorprop 
 
 
 
 
 
2-(4-chloro-2-
methylphenoxy)propionic 
acid 
 
 
Mecoprop 
  
 
 
 
Naproxen 
  
 
 
Fig. 9 (continued): Acidic analytes for the evaluation of zwitterionic chiral 
stationary phases 
 
 
 
 
 
1.1.1) Tau-QN and Tau-QD 
 
Both tau-QN and tau-QD were able to enantioseparate all of the acidic analytes em-
ployed in this study with the exception of Naproxen (not separable on any of the CSPs 
tested) and Z-β-phenylalanine (not separable on Tau-QD): 
 
It has been mentioned before that selector density on the CSP surface was significantly 
higher for Tau-QN than for Tau-QD. This was reflected in the retention factors k1 and k2, 
which were always smaller on tau-QD. Nevertheless, enantioselectivites α of the two 
pseudo-enantiomeric CSPs are comparable and obviously not dependent on the reten-
tion time. For example, the overall highest enantioselectivity and resolution were 
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achieved for DNB-phenylalanine on Tau-QD, where the retention factors of the two en-
antiomers are less than 50 % (k1) and 60 % (k2) of those of Tau-QN (see  Table 1.3). 
 
 
Acidic Tau-QN (205 µmol SO/g silica) Tau-QD (150 µmol SO/g silica) 
Analytes k1 k2 alpha Res. N1[m-1] N2[m-1] k1 k2 alpha Res. N1[m-1] N2[m-1] 
Fmoc-Phe 0,83 1,08 1,31 1,69 19513 16413 0,41 0,54 1,33 1,52 23427 36460 
Fmoc -Ser 0,72 0,98 1,35 1,86 21387 18413 0,36 0,55 1,54 1,89 14333 35893 
Z-Phe 0,48 0,56 1,16 0,62 12193 20287 0,23 0,28 1,23 0,65 24200 30053 
Z-beta-Phe 0,19 0,28 1,48 1,28 30520 32180 0,15 0,15 1,00    
Ac-Trp 0,53 0,93 1,75 3,48 29013 21760 0,27 0,52 1,96 3,53 40193 38893 
DNB-Glu 1,06 4,20 3,95 8,44 16673 8660 0,44 1,73 3,93 10,39 32500 29160 
DNB-Asp 2,60 4,90 1,88 4,41 9467 8613 1,63 2,18 1,34 2,99 28427 25747 
DNB-Phe 1,42 7,62 5,36 9,55 13073 6820 0,63 4,13 6,61 16,31 37240 23967 
DNP-Glu 1,89 2,48 1,31 1,83 11127 10160 0,80 1,01 1,25 1,85 34313 31880 
DNP-Asp 2,53 3,62 1,43 2,44 9460 8560 0,99 1,33 1,34 2,74 34713 31400 
Dichlorprop 0,41 0,56 1,36 1,34 20667 18913 0,17 0,32 1,96 2,49 43947 38367 
Mecoprop 0,26 0,33 1,28 0,87 25907 24620 0,11 0,18 1,68 1,34 37327 54253 
Naproxen 0,31 0,31 1,00    0,19 0,19 1,00    
Table 1.3: Results of Tau-QN and Tau-QD evaluation with acidic analytes. 
 
 
As depicted in Figure 10, selectivities of Tau-QN and Tau-QD, respectively, are of com-
parable magnitude for most acidic analytes, but many enantiomers are slightly better 
separated on Tau-QD: 
 
 
Figure 10: Selectivities of pseudo-enantiomeric tau-QN and tau-QD ZWIX CSPs 
for acidic analytes 
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In part, this can be attributed to the fact that the Tau-QN column that was used in these 
experiments had also been subjected to stress-tests and other demanding analyses 
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before, which could have led to column bleeding and thus impaired the column´s sepa-
ration performance. The fact that the Tau-QN column performance obtained in the ex-
periments for this thesis was significantly poorer than its performance in earlier analyses 
further confirms this suspicion. 
(Nevertheless, Homotau-QD and Homohomotau-QD, too, exhibited slightly (or, in the 
case of DNB-Phe, significantly) better separation capabilities for acidic analytes than 
their pseudo-enantiomeric counterparts (see Figures 16 and 18).) 
 
DNB protected amino acids were particularly well separated. According to 32, the reason 
for this is a combination of ionic interactions and the extremely advantageous 
π−π interaction of the electron-poor (π-acidic) aromatic substituent (DNB) of the selec-
tand and the electron-rich (π-basic) quinoline moiety of the selector. Hydrogen bonding 
between the carbamate function of the selector and the amide of the DNB-protected 
acid is crucial for the enantiodiscrimination. 
In contrast, the enantioseparation of amino acids with a DNP protective group was not 
nearly as successful, which is due to the lack of an amide bond in the analyte. 
 
As a rule of thumb, on QN-based CSPs the D enantiomer of a chiral analyte is eluted 
before the L enantiomer (there are some exceptions to this, such as DNP-glutamic acid 
and DNP-aspartic acid). 
Elution order is usually inverted with QD-based chiral stationary phases, where with 
most analytes the L enantiomer is eluted before the D enantiomer. 
These presuppositions were confirmed for all acidic analytes on Tau-QN and Tau-QD. 
Fig. 11 illustrates the reversal of elution order for the acidic analytes Ac-Trp and DNP-
Glu. Elution orders were determined by injection of an enantiomerically pure (either D or 
L) sample of the analyte. 
 
Table 1.4 presents the elution orders of acidic analytes on Tau-QN and Tau-QD. 
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Tau-QN 
 
Analyte 
 
Tau-QD 
 
 
 
 
 
 
Ac-Trp 
 
 
 
 
 
 
 
 
DNP-Glu 
 
Fig. 11: Reversal of elution order for acidic analytes on Tau-QN and Tau-QD CSPs. 
α=1,75 
R=3,48 
D L 
α=1,96
R=3,53
D L
α=2,16 
R=3,54 
L D D L 
α=1,25
R=1,85
 
 
 
Analyte EO* (Tau-QN) EO* (Tau-QD) 
 
Fmoc-Phe 
 
D 
 
L 
Z-Phe D L 
Z-β-Phe D no sep. 
Ac-Trp D L 
Fmoc-Ser D L 
DNB-Phe D n.d. 
DNP-Glu L D 
DNP-Asp L D 
   
Table 1.4: Elution orders of acidic analytes on Tau-QN and Tau-QD. (* EO: Kon-
figuration of first eluted enantiomer) 
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1.1.2) Homotau-QN and Homotau-QD 
 
All acidic analytes with the exception of Naproxen could be enantioseparated on Homo-
tau-QN and Homotau-QD. 
 
 
Acidic Homotau-QN (280 µmol SO/g silica) Homotau-QD (188 µmol SO/ g silica) 
Analytes k1 k2 alpha Res. N1[m-1] N2[m-1] k1 k2 alpha Res. N1[m-1] N2[m-1] 
Fmoc-Phe 1,37 1,79 1,30 2,80 32960 32093 0,56 0,71 1,28 1,52 25720 29960 
Fmoc -Ser 1,30 1,69 1,30 2,81 35820 33727 0,50 0,66 1,34 1,50 16513 28273 
Z-Phe 0,86 0,99 1,14 1,17 35773 36160 0,33 0,39 1,19 0,60 22347 16700 
Z-beta-Phe 0,40 0,76 1,90 3,99 24467 23033 0,12 0,20 1,62 1,20 40660 34067 
Ac-Trp 1,01 1,88 1,87 6,77 41987 36293 0,37 0,69 1,87 3,76 33193 34667 
DNB-Glu 2,44 11,48 4,70 16,91 29780 22400 0,87 3,48 3,99 11,77 19287 23233 
DNB-Asp 7,41 >12 >1,62 n.d. n.d. n.d. 3,26 4,01 1,23 1,98 15460 17080 
DNB-Phe 2,70 15,29 5,67 18,29 35453 35467 1,04 5,09 4,87 15,19 24933 24993 
DNP-Glu 4,93 6,14 1,25 2,78 26293 22193 1,61 1,81 1,13 1,11 24607 22147 
DNP-Asp 6,83 10,04 1,47 5,19 25107 24893 2,18 2,67 1,23 1,87 16807 18820 
Dichlorprop 0,86 1,08 1,25 2,21 44033 41727 0,30 0,49 1,64 2,56 39093 35733 
Mecoprop 0,53 0,64 1,20 1,44 47600 46860 0,20 0,28 1,44 1,25 34780 34713 
Naproxen 0,43 0,43 1,00       0,22 0,22 1,00       
Table 1.5: Results of Homotau-QN and Homotau-QD CSP evaluation with acidic 
analytes. 
 
 
 
 
Even though there was a significant difference in the retention factors of the individual 
analyte enantiomers on Homotau-QN and Homotau-QD, the respective selectivity coef-
ficients α were almost always very similar (Table 1.4)  
 
. 
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Selectivities of Homotau-QN and Homotau-QD CSPs for Acidic 
Analytes
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Fig. 12: Selectivities of pseudo-enantiomeric Homotau-QN and Homotau-QD ZWIX 
CSPs for acidic analytes 
 
 
With the exception of DNP-glutamic acid and DNP-aspartic acid, the L enantiomers of 
the acidic analytes were eluted from the Homotau-QN column after the D enantiomers 
(elution order of Z-β-phenylalanine could not be determined due to lack of an enanti-
omerically pure sample). 
In all cases, elution order was reversed on Homotau-QD with L eluting before D (D be-
fore L for DNP-glutamic acid and DNP-aspartic acid) (Figure 13). 
 
 
 
Homotau-QN 
 
Analyte 
 
Homotau-QD 
 
 
 
 
 
 
Ac-Trp 
 
Fig. 13: Reversal of elution order for an acidic analyte on Homotau-QN and Homo-
tau-QD CSPs. 
α=1,89 
R=6,74 
L 
D 
α=1,87
R=3,76
D L
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Table 1.6 presents the elution orders of chiral acidic analytes on Homotau-QN and 
Homotau-QD. 
 
 
Analyte EO* (Homotau-QN) EO* (Homotau-QD) 
 
Fmoc-Phe D L 
Z-Phe D L 
Ac-Trp D L 
Fmoc-Ser D L 
DNP-Glu L D 
DNP-Asp L D 
   
Table 1.6: Elution orders of acidic analytes on Homotau-QN and Homotau-QD. (* 
EO: Konfiguration of first eluted enantiomer) 
 
 
 
1.1.3) Homohomotau-QN and Homohomotau-QD 
 
Homohomotau-QN and Homohomotau-QD were able to separate all chiral acidic ana-
lytes except for Naproxen (Table 1.7). 
 
Acidic Homohomotau-QN (254 µmol SO / g silica) Homohomotau-QD (187 µmol SO / g silica) 
Analytes k1 k2 alpha Res. N1[m-1] N2[m-1] k1 k2 alpha Res. N1[m-1] N2[m-1] 
Fmoc-Phe 1,40 1,86 1,33 2,74 28007 25527 0,44 0,59 1,34 1,50 22507 26927 
Fmoc -Ser 1,35 1,77 1,31 2,39 26693 19940 0,39 0,54 1,38 1,36 15027 24867 
Z-Phe 0,93 1,07 1,15 1,22 34887 32400 0,25 0,31 1,25 0,69 21467 20613 
Z-beta-Phe 0,30 0,41 1,34 1,52 63667 32247 0,11 0,17 1,59 1,03 41507 35193 
Ac-Trp 1,03 1,70 1,65 4,86 32927 30653 0,30 0,49 1,64 2,28 26900 31793 
DNB-Glu 2,61 10,71 4,10 15,07 24453 21027 0,60 2,53 4,23 11,71 27727 24960 
DNB-Asp 8,51 11,87 1,40 3,66 14180 17300 2,08 2,74 1,32 2,73 21540 20333 
DNB-Phe 2,74 12,95 4,73 n.d. n.d. n.d. 0,77 4,22 5,49 12,79 14640 19347 
DNP-Glu 5,57 6,53 1,17 1,90 21240 20773 1,20 0,14 1,14 1,17 27673 26193 
DNP-Asp 8,39 11,57 1,38 3,88 19193 19360 1,50 1,87 1,25 2,11 25520 24633 
Dichlorprop 1,04 1,26 1,21 1,77 33440 32733 0,22 0,37 1,65 1,95 32280 32640 
Mecoprop 0,68 0,78 1,16 1,14 38847 15393 0,14 0,21 1,43 0,89 30780 30787 
Naproxen 0,43 0,43 1,00       0,20 0,20 1,00       
Table 1.7: Results of Homohomotau-QN and Homohomotau-QD CSP evaluation 
with acidic analytes. 
 
Again, due to the lower surface coverage of the QD selector, enantiomer retention fac-
tors k1 and k2 were significantly smaller on Homohomotau-QD than on Homohomotau-
QN. Nevertheless, enantioselectivities of the two CSPs were comparable or even higher 
on Homohomotau-QD, which further supports the statement made above that selectivity 
is not necessarily dependent on the retention times of the analytes (Figure 14). 
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Resolution, though, was almost always higher on Homohomotau-QN which can be at-
tributed to the higher selector coverage of this CSP. 
Similarly to the taurine and homotaurine selectors, the best results were obtained for 
DNB protected amino acids. This illustrates the importance of H-bonding between the 
carbamate moiety of the selector and the amide of the selectand. 
 
 
Selectivities of Homohomotau-QN and Homohomotau-QD CSPs 
for Acidic Analytes
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Fig. 14 : Selectivities of pseudo-enantiomeric Homohomotau-QN and Homoho-
motau-QD ZWIX CSPs for acidic analytes 
 
 
Elution order for acidic analytes on Homohomotau-QN was usually D before L. This or-
der was inverted in all cases on Homohomotau-QD (Figure 15, Table 1.8). 
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Homohomotau-QN 
 
Analyte 
 
Homohomotau-QD 
 
 
 
 
 
 
Ac-Trp 
 
Fig. 15: Reversal of elution order for an acidic analyte on Homohomotau-QN and 
Homohomotau-QD CSPs. 
α=1,69 
R=5,02 
D L 
α=1,64
R=2,28
D L
 
 
 
Table 1.8 presents elution orders of acidic analytes on Homohomotau-QN and Ho-
mohomotau-QD. 
 
 
Analyte EO* 
(Homohomotau-QN) 
EO* 
(Homohomotau-QD) 
 
Fmoc-Phe D L 
Z-Phe D L 
Z-β-Phe n.d. n.d. 
Ac-Trp D L 
Fmoc-Ser D L 
DNB-Phe D n.d. 
DNP-Glu L D 
DNP-Asp L D 
   
Table 1.8: Elution orders of acidic analytes on Homohomotau-QN and Ho-
mohomotau-QD. (* EO: Konfiguration of first eluted enantiomer) 
 
 
 
1.2) Amphoteric (Zwitterionic) Analytes 
 
In amphoteric molecules, both acidic and basic functional groups are present. These 
functional groups are protonated or deprotonated according to the pH of their surround-
ing environment. At a certain pH which is characteristic for every amphoteric compound, 
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the net charge of the molecule will be zero. This pH is called the isoelectric point of the 
substance and can be calculated from the pka values of the functional groups. Above 
and below this pH, the compound has a positive or negative net charge resulting from 
the predominant protonation of basic or deprotonation of acidic functional groups, re-
spectively. This means that in most of the pH range, amphoteric compounds exist as 
zwitterions (positive and negative charges within one molecule). 
Zwitterionic analytes cannot be separated on conventional cation or anion exchangers. 
This is due to the second charge present in the selectand which has the same name as 
the ion exchanger and acts as an intramolecular counterion that prevents retention. 
Therefore it is necessary to use zwitterionic chiral ion exchangers (ZWIX) such as the 
ones presented here. 
Figure 16 shows the chiral amino acids used as zwitterionic analytes in this study and 
their structures. 
All experiments were carried out with a mobile phase of methanol with 50 mM formic 
acid and 25 mM DEA, which corresponds to a slightly acidic apparent pH of 5,4. 
 
 
Amino Acid Symbol Structural  
Formula 
 
Amino 
Acid 
Symbol Structural 
Formula 
 
 
Phenyl-
alanine 
 
 
 
Phe 
 
 
 
 
β-Phenyl-
alanine 
 
 
 
β-Phe  
 
 
 
 
α-Methyl-
phenylalanine 
 
 
 
α-Me- 
Phe 
 
 
 
 
 
 
β-Homo-
Phenyl-
alanine 
 
 
 
β−Homo- 
Phe 
 
 
 
 
 
 
 
Tryptophane 
 
 
 
 
Trp 
 
 
 
 
 
1-Methyl-
tryptophane 
 
 
 
 
1-Me-Trp 
 
 
 
Fig. 16: Chiral amphoteric (zwitterionic) analytes for ZWIX evaluation 
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α-Methyl-
tryptophane 
 
 
 
α-Me-
Trp 
 
 
 
 
 
5-Hydroxy-
tryptophane 
 
 
 
5-OH-Trp 
 
 
 
 
 
Tyrosine 
 
 
 
Tyr 
 
 
 
 
α-Methyl- 
tyrosine 
 
 
α-Me-Tyr 
 
 
 
 
α-Methyl- 
meta-
Tyrosine 
 
 
α-Me-
m-Tyr 
 
 
 
 
 
3,4-
Dihydroxy-
phenyla-
lanine 
 
 
 
DOPA 
 
 
 
 
 
α-Methyl- 
3,4-
dihydroxy-
phenylalanine 
 
 
 
α-Me-
DOPA 
 
 
 
 
para-
Bromo-
phenyla-
lanine 
 
 
p-Br-Phe 
 
 
 
    
 
para-
Chloro-
phenylala-
nine 
 
 
p-Cl-Phe 
 
 
 
 
Fig. 16 (continued): Chiral amphoteric (zwitterionic) analytes for ZWIX evaluation 
 
 
 
1.2.1) Tau-QN and Tau-QD 
  
Enantioseparation of several chiral zwitterionic (amphoteric) compounds on both Tau-
QN and Tau-QD was not satisfactory: Tau-QN could only separate 5 out of 10 analytes 
with relatively small resolution values, Tau-QD separated 7 out of 10.  
Even though the selector surface coverage of Tau-QD is significantly lower and there-
fore retention times are shorter, higher resolution and higher plate numbers were 
achieved with the latter CSP compared to tau-QN (Table 1.6). 
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Zwitterionic Tau-QN (205 µmol SO / g silica) Tau-QD (150 µmol SO / g silica) 
Analytes k1 k2 alpha Res. N1[m-1] N2[m-1] k1 k2 alpha Res. N1[m-1] N2[m-1] 
Phe 0,72 0,76 1,04 0,42 73713 42367 0,46 0,46 1,00       
beta−Phe 1,35 1,35 1,00       0,93 1,01 1,09 0,78 47640 33000 
alpha-Me-Phe 0,03 0,03 1,00       0,38 0,47 1,25 1,37 49433 43993 
Trp 1,43 2,18 1,53 4,31 24887 29847 0,80 1,10 1,39 3,01 40280 38573 
alpha-Me-Trp 1,33 3,22 2,42 10,34 34853 33900 0,72 1,68 2,35 8,38 41547 37440 
DOPA 1,46 1,46 1,00       0,72 0,72 1,00       
alpha-Me-DOPA 1,09 1,57 1,44 3,36 27000 29113 0,56 0,88 1,57 3,51 39893 37813 
p-Br-Phe 1,02 1,02 1,00       0,11 0,61 5,45 7,38 50000 39760 
p-Cl-Phe 0,9 0,9 1,00       0,09 0,54 6,28 6,40 30407 41793 
Tyr 0,91 0,97 1,07 0,46 38093 16787 0,50 0,50 1,00       
Table 1.9: Results of Tau-QN and Tau-QD CSP evaluation with zwitterionic analytes
 
 
DOPA was the only compound that could neither be separated on Tau-QN nor on Tau-
QD. Interestingly, all other analytes not enantioseparated by Tau-QN were separable on 
tau-QD and vice versa (Figure 17). 
 
 
Figure 17: Selectivities of pseudo-enantiomeric Tau-QN and Tau-QD ZWIX CSPs for 
zwitterionic analytes 
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Analyte EO* (Tau-QN) EO* (Tau-QD) 
Phe D no separation 
Trp D n.d. 
Tyr D no separation 
Table 1.10: Elution orders of amphoteric analytes on Tau-QN and Tau-QD. (* EO: 
Konfiguration of first eluted enantiomer 
 
 
 
Nevertheless, enantioselectivites were generally small, especially for the unprotected 
amino acids phenylalanine, β-phenylalanine and tyrosine. Eye-catching exceptions are 
the para substituted aromatic amino acids p-Br-Phe and p-Cl-Phe, whose selectivity 
coefficients on Tau-QD are higher than 5. However, the high enantioselectivity values 
are due to particularly short retention times. It remains to be investigated in more detail 
if there exists a beneficial influence of the substituents on the π-acidity of the analytes. 
 
It is also remarkable that a methyl substituent in α position to the carboxyl group signifi-
cantly enhances enantioselectivity (see Figure 17: Phe – α-Me-Phe, Trp – α-Me-Trp, 
DOPA – α-Me-DOPA). 
 
On Tau-QN, the D enantiomers of phenylalanine, tryptophane and tyrosine were eluted 
before their respective L enantiomers (Phe and Tyr could not be separated on Tau-QD). 
 
 
1.2.2) Homotau-QN and Homotau-QD 
 
Homotau-QN and Homotau-QD were able to enantioseparate, albeit with rather low se-
lectivities, the majority of amphoteric (zwitterionic) analytes (Table 1.11).The relatively 
short retention times (< 10 min) reflected in retention factors below 6 produced accept-
able resolution values nevertheless. 
Enantioselectivities for zwitterionic analytes were mostly between 1 and 2, with the strik-
ing exception of β-Phe (Figure 18). Apparently, in this case the proportions of the selec-
tor and the selectand are particularly favourable to achieve discrimination of one enanti-
omer. 
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Zwitterionic Homotau-QN (280 µmol SO/ g silica) Homotau-QD (188 µmol SO / g silica) 
Analytes k1 k2 alpha Res. N1[m-1] N2[m-1] k1 k2 alpha Res. N1[m-1] N2[m-1] 
Phe 0,89 1 1,12 1,14 47047 43173 0,45 0,45 1,00       
beta−Phe 1,92 3,6 4,73 14,01 108787 43333 0,12 0,75 6,45 8,21 43240 33613 
alpha-Me-Phe 0,79 1,05 1,32 2,50 37713 37973 0,38 0,48 1,28 1,31 34453 33093 
Trp 1,91 3,55 1,86 7,95 35760 34107 0,83 1,25 1,50 3,41 30900 29267 
alpha-Me-Trp 1,83 5,65 3,10 14,31 36540 32420 0,87 0,96 1,11 0,73 23540 23607 
DOPA 1,62 1,96 1,21 2,03 28980 28620 0,66 0,73 1,10 0,56 37307 16453 
alpha-Me-DOPA 1,49 2,28 1,54 4,84 35207 31527 0,60 0,85 1,42 2,39 29333 28740 
p-Br-Phe 1,25 1,35 1,08 0,71 27780 23840 0,62 0,62 1,00       
p-Cl-Phe 1,09 1,18 1,08 0,67 33213 26293 0,55 0,55 1,00       
Tyr 1,15 1,34 1,16 1,35 30613 27927 0,23 0,55 2,39 2,69 17553 12860 
Table 1.11: Results of Homotau-QN and Homotau-QD evaluation with zwitterionic 
(amphoteric) analytes. 
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Fig. 18: Selectivities of pseudo-enantiomeric Homotau-QN and Homotau-QD ZWIX 
CSPs for zwitterionic analytes 
  
 
Reversal of elution order of amphoteric analytes was achieved on Homotau-QN and 
Homotau-QD (Figure 19, Table 1.12). 
 
 
Elution orders were determined by injection of enantiomerically pure samples of the 
analyte. 
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Homotau-QN 
 
Analyte 
 
Homotau-QD 
 
 
 
 
  
β-Phe 
 
Fig. 19: Reversal of elution order for an amphoteric analyte on Homotau-QN and 
Homotau-QD CSPs. 
α=4,73 
R=14,01 
L 
D 
α=6,45
R=8,21
D 
L
 
 
 
Analyte EO* (Homotau-QN) EO* (Homotau-QD) 
 
Phe D no sep. 
Trp D n.d. 
Tyr D n.d. 
   
Table 1.12: Elution orders of amphoteric analytes on Homotau-QN and Homotau-
QD. (* EO: Konfiguration of first eluted enantiomer) 
 
 
 
 
1.2.3) Homohomotau-QN and Homohomotau-QD 
 
 
Whereas half of the zwitterionic chiral analytes remained unseparated on Homohomo-
tau-QD, enantioseparation was achieved in all cases on Homohomotau-QN (Table 
1.13).  
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Zwitterionic Homohomotau-QN (254 µmol SO / g silica) homohomotau-QD (187 µmol SO / g silica) 
Analytes k1 k2 alpha Res. N1[m-1] N2[m-1] k1 k2 alpha Res. N1[m-1] N2[m-1] 
Phe 0,56 0,62 1,11 0,63 31980 23187 0,44 0,44 1,00       
beta−Phe 0,87 0,93 1,07 0,55 49933 27033 0,11 0,85 7,99 9,24 41060 33420 
alpha-Me-Phe 0,47 0,63 1,32 1,78 34280 35187 0,38 0,46 1,23 1,02 31507 29280 
Trp 1,19 1,98 1,67 5,04 29800 28307 0,83 1,06 1,27 1,75 24460 23360 
alpha-Me-Trp 1,11 2,96 2,67 9,81 30680 26233 0,83 0,89 1,07 0,48 44860 18560 
DOPA 1,00 1,21 1,21 1,50 24067 23053 0,74 0,74 1,00       
alpha-Me-DOPA 0,95 1,44 1,53 3,28 23200 21847 0,62 0,84 1,36 1,84 22780 21147 
p-Br-Phe 0,76 0,83 1,09 0,61 34913 22393 0,59 0,59 1,00       
p-Cl-Phe 0,68 0,74 1,09 0,58 41400 22587 0,53 0,53 1,00       
Tyr 0,75 0,87 1,15 0,77 17600 14860 0,55 0,55 1,00       
Table 1.13: Results of Homohomotau-QN and Homohomotau-QD CSP evaluation 
with zwitterionic analytes 
 
 
The respective chromatographic resolution was acceptable and led to a baseline sepa-
ration for many of the analytes. 
Even though the selectivity of homohomotau-QD was low or even resulted in an α value 
of 1 (no separation) in most cases, the overall highest enantioselectivity was obtained 
on this CSP, namely for β-phenylalanine (Figure 20). 
 
 
 
Fig. 20: Selectivities of pseudo-enantiomeric Homohomotau-QN and 
Homohomotau-QD ZWIX CSPs for zwitterionic analytes 
Selectivities of Homohomotau-QN and Homohomotau-QD 
CSPs for Zwitterionic Analytes
0
1
2
3
4
5
6
7
8
Ph
e
be
ta-
Ph
e
alp
ha
-M
e-P
he Trp
alp
ha
-M
e-T
rp
DO
PA
alp
ha
-M
e-D
OP
A
p-B
r-P
he
p-C
l-P
he Ty
r
al
ph
a Homohomotau-QN
Homohomotau-QD
 
 
 
 
 
 
76
Elution orders on Homohomotau-QN were determined for Phe, Trp and Tyr by injection 
of an enantiomerically pure sampe into the HPLC system. In all three cases, the D en-
antiomers were eluted first (Figure 21). 
 
 
 
Homohomotau-QN 
 
Analyte 
 
Homohomotau-QD 
 
 
 
  
Trp 
 
Fig. 21: Reversal of elution order for an amphoteric analyte on Homohomotau-QN 
and Homohomotau-QD CSPs. 
α=1,27
R=1,75
D L
α=1,67 
R=5,04 
D L
 
 
 
Table 1.14 depicts the elution orders obtained for zwitterionic analytes on Homohomo-
tau-QN and Homohomotau-QD CSPs. 
 
 
 
Analyte EO* 
(Homohomotau-QN) 
EO* 
(Homohomotau-QD) 
Phe D no sep. 
Trp D n.d. 
Tyr D n.d. 
Table 1.14: Elution orders of amphoteric analytes on Homohomotau-QN and 
Homohomotau-QD. (* EO: Konfiguration of first eluted enantiomer) 
 
 
1.3) Peptide Enantiomers 
 
Due to their amphoteric nature and chirality, peptides represent promising targets for 
enantioseparation on zwitterionic chiral stationary phases, especially since the ZWIX 
CSPs offer an opportunity to separate peptides without the need for derivatisation. 
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Figure 22 presents the amino acids that comprise the building blocks of the peptides 
investigated as well as their pKa values. 
 
In this study, different groups of peptides were investigated: Mixed peptides consisting 
of two or three amino acids as well as homologous peptides on the basis of amino acids 
alanine and valine. 
The analytes to be separated on the zwitterionic chiral stationary phases were all-L and 
all-D enantiomers of the individual peptides shown in Figure 23. 
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Structure Sym-
bol 
Amino Acid Structure Sym-
bol 
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Fig. 22: Amino acid building blocks for peptides investigated in this work 
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Mixed Dipeptides 
 
 
 
Pro-Phe 
 
 
 
 
 
Gly-Trp 
 
 
 
 
 
 
Ala-Phe 
 
 
 
 
 
Gly-Pro 
 
 
 
 
 
Gly-Phe 
 
 
 
 
 
 
Pro-Gly 
 
 
 
 
 
Gly-Val 
 
 
 
 
 
Gly-Thr 
 
 
 
 
 
Gly-Leu 
 
 
 
 
 
 
Gly-Asp 
 
 
 
 
 
Ala-Val 
 
 
  
Tripeptides 
 
 
 
Ala-Gly-
Gly 
 
 
 
 
Gly-Gly-
Ala 
 
 
 
 
 
Fig. 23: Di-, tri- and oligopeptides used in the evaluation of ZWIX CSPs. 
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Tripeptides (continued) 
 
 
Ala-Gly-
Ala 
 
  
 
Homologous Ala Peptides 
 
 
Ala-2 
 
 
 
Ala-3 
 
 
 
Ala-4 
 
 
 
Ala-5 
 
 
 
Ala-6 
 
 
Homologous Valine Peptides 
 
Val-2 
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Val-5 
 
Val-6 
 
 
Fig. 23 (continued): Di-, tri- and oligopeptides used in the evaluation of ZWIX 
CSPs. 
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Even though the retention of peptides was significantly higher on the QN CSPs than on 
the QD-based ones due to the lower selector loadings of the latter, mixed dipeptides 
were better separable on QD CSPs (Figure 24). 
In contrast, QN CSPs often exhibited better separation capabilities for homologous 
valine peptides. 
Alanine peptides, too, were slightly better separated on QD-based CSPs. 
Similar to acidic and other zwitterionic analytes, the elution order for peptides on QN-
based CSPs was usually all-D before all-L and the other way around for QD-based sta-
tionary phases. 
 
 
 
 
Fig. 24: Selectivity factors of ZWIX CSPs for peptide enantiomers (mobile phase: 
methanol, 50 mM FA, 25 mM DEA, 1 mL/min, CAD detection). 
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Selectivities of Homohomotau-QN and Homohomotau-QD 
CSPs for Pepide Enantiomers
0,00
0,50
1,00
1,50
2,00
2,50
Pr
o-P
he
Ala
-P
he
Gl
y-P
he
Gl
y-V
al
Gl
y-L
eu
Ala
-V
al
Ala
-2
Ala
-3
Ala
-4
Ala
-5
Ala
-6
Va
l-2
Va
l-3
Va
l-4
al
ph
a
Homohomotau-QN
Homohomotau-QD
Fig. 24 (continued): Selectivity factors of ZWIX CSPs for peptide enantiomers 
enantiomers (mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min, CAD 
detection) 
 
 
 
2.) Comparison of Homologous ZWIX Selectors 
 
 
 
 
 
 
R 
 
selector aminosulfonic acid 
 
(CH2)2SO3- 
tau-QN,  
tau-QD 
 
  
taurine 
 
 
(CH2)3SO3- 
homotau-QN 
homotau-QD 
 
 
homotaurine 
 
 
(CH2)4SO3- 
homohomotau-QN, 
homohomotau-QD 
 
  
homohomotaurine 
Fig. 25: Structure of zwitterionic selectors. Red: Cation exchanging site (sulfonic 
acid), blue: anion exchanging site (protonated quinuclidine moiety) 
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 Figure 25 shows a ZWIX selector based on a sulfonic acid cation exchanging site (R) 
and an amine anion exchanging site (protonated quinuclidine nitrogen atom): 
 
 
In the course of this work, selectors with homologous sulfonic acid cation exchanging 
sites R were prepared. 
These “homologous” selectors were evaluated for their enantioseparation capabilities 
with acidic and zwitterionic chiral analytes (for structural formulae, see 1.1. and 1.2) and 
the results were compared for the three QN-based selectors tau-QN, homotau-QN and 
homohomotau-QN as well as for tau-QD, homotau-QD and homohomotau-QD. 
 
 
2.1) Comparison of Quinine-Based ZWIX selectors 
 
The tau-QN, homotau-QN and homohomotau-QN CSPs employed in this study possess 
comparable selector loadings between 250 and 280 µmol selector/g silica.  
The mobile phase used was methanol with formic acid and diethylamine as additives 
and with a pH of 5,4. 
Detection was achieved by a UV detector for acidic and zwitterionic analytes and by a 
CAD detector for peptides. 
 
Elution order on QN-based CSPs is usually D before L. This aspect was discussed in 
the previous section and will therefore not be regarded here. 
 
 
2.1.1) Acidic Analytes 
 
As shown in Figure 26 (more detailed results: appendix, Table A1), most acidic analytes 
could be enantioseparated on all 3 quinine-based stationary phases. Only very few, 
namely the protected amino acid Z-proline and the acidic anti-inflammatory drug 
Naproxen, however, could not be separated into their respective enantiomers on either 
tau-QN, homotau-QN or homohomotau-QN. 
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Selectivity of QN-based CSPs for Acidic Analytes
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Fig. 26: Enantioselectivity of QN-based CSPs for acidic analytes (mobile phase: 
methanol, 50 mM FA, 25 mM DEA, 1 mL/min, CAD detection). 
 
 
Even though retention times for the individual analytes varied between the three qui-
nine-based CSPs, enantioselectivities were almost always of comparable magnitude on 
all three. The corresponding resolutions are shown in Figure 27. 
With acidic analytes, high enantioselectivity is always connected with good resolution. 
 
Resolution of QN-based CSPs for Acidic Analytes
0
5
10
15
Fm
oc
-P
he
Fm
oc
 -S
er
Z-P
he
Z-b
eta
-P
he
Z-P
ro
Ac
-P
he
Ac
-P
ro
Ac
-Tr
p
DN
B-
Gl
u
DN
B-
As
p
DN
B-
Ph
e
DN
P-
Gl
u
DN
P-
As
p
Dic
hlo
rpr
op
Me
co
pro
p
Na
pro
xe
n
al
ph
a Tau-QN
Homotau-QN
Homohomotau-QN
 
 
Fig. 27: Resolution (R) obtained for acidic analytes on QN-based ZWIX CSPs (mobile 
phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min). Note: Resolution of DNB-Phe on 
Hhtau-QN was not determined. 
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There is no recognisable trend along the line of tau-QN, homotau-QN and homohomo-
tau-QN as to which CSP is the most capable one for the separation of acidic analytes, 
although homotau-QN appears very promising. 
 
 
2.1.2) Zwitterionic Analytes 
 
Compared to the acidic analytes, a relatively large number of zwitterionic compounds 
could not be separated on either of the QN-based ZWIX CSPs. The reason for this is 
probably the fact that the selectors used in this study lack a stereogenic center in the 
vicinity of the SO3- moiety (SCX site). From this, one may deduct that the separation of 
free amino acids on ZWIX selectors with a chiral cation exchanging site will have a 
higher chance of success. 
The best enantioseparations were obtained for α-methyl substituted amino acids, which 
indicates the importance of the substituents at the chiral center (Figure 28). 
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Fig. 28: Enantioselectivity of QN-based CSPs for zwitterionic (amphoteric) analytes 
(mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min). 
 
 
The corresponding resolutions are depicted in Figure 29:  
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Resolution on QN-based ZWIX CSPs
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Fig. 29: Resolution (R) obtained for zwitterionic analytes on QN-based ZWIX CSPs 
(mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min). 
 
 
Of the three CSPs investigated here, homotau-QN seems more suitable for the separa-
tion of amphoteric compounds than its “homologues”, but certainly both homotau-QN 
and homohomotau-QN performed better than the tau-QN CSP. 
 
 
2.1.3) Mixed Di- and Tripeptides 
 
Even though retention times were shortest on homohomotau-QN due to its compara-
tively low selector loading, it performed especially well in the peptide separation experi-
ment and was able to separate all but 2 of the 14 mixed di- and tripeptides investigated 
(Figure 30). It achieved higher selectivities for most of the analytes than its shorter 
homologues (details: see table A2, appendix). 
 
The corresponding R (resolution) values obtained for peptides on QN-based ZWIX 
CSPs are shown in Figure 31. 
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Fig. 30: Selectivity of QN-based ZWIX CSPs for all-D and all-L enantiomers of 
mixed di- and tripeptides (mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 
mL/min). 
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It is probably due to the length of the alkanesulfonic acid moiety (and hence, the dis-
tance and flexibility between the cation and anion exchanging sites) in the selector that 
homohomotau-QN was able to separate two out of three tripeptides that were insepara-
ble on the two other CSPs. 
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Fig. 31: Resolution (R) obtained for peptides on QN-based ZWIX CSPs (mobile 
phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min). 
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2.1.4) Homologous Peptides 
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Fig. 32: Selectivity of QN-based ZWIX CSPs for all-D and all-L enantiomers of ho-
mologous all-L and all-D alanine and valine peptides (mobile phase: methanol, 50 
mM FA, 25 mM DEA, 1 mL/min, CAD detection). 
 
 
Separation was accomplished for the all-L and all-D enantiomers of all alanine and 
valine peptides investigated, and again, the enantioselectivity of homohomotau-QN 
stood out (Table 2, appendix). 
Resolution values for homologous peptides are shown in Figure 33. 
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Fig. 33: Resolution (R) obtained for homologous peptides on QN-based ZWIX CSPs 
(mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min, CAD detection). 
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The peptide enantioseparation results are discussed in more detail in section 3.2.1. 
 
 
 
2.2) Comparison of Quinidine-Based ZWIX selectors 
 
 
The quinidine-based selectors tau-QD, homotau-QD and homohomotau-QD investi-
gated in this study possess selector loadings between 150 (tau-QD) and 188 (homoho-
motau-QD) µmol selector /g silica. 
As pseudo-enantiomers of the quinine-based selectors, their usual elution order of en-
antiomers is L before D. 
The comparative experiments were carried out with a mobile phase of methanol with 50 
mM of formic acid and 25 mM of diethylamine (pH = 5,4) at room temperature and with 
UV (acidic and zwitterionic analytes and aromatic peptides) and CAD (peptides) detec-
tion. 
 
 
2.2.1) Acidic Analytes 
 
 
Most analytes could be separated on all 3 quinidine-based CSPs. Tau-QD offered the 
highest enantioselectivities (alpha), especially for DNB-protected acids (Figure 34). 
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Fig. 34: Enantioselectivities of tau-QD, homotau-QD and homohomotau-QD for 
acidic analytes (mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 mL/min). 
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Interestingly, tau-QD was not able to separate Z-β-Phe whereas the two other CSPs 
achieved reasonable separation of this compound. Presumably the position of the aro-
matic protective group (α and β, respectively, in Phe and β-Phe) is of crucial importance 
to the enantioselective interaction between selecand and selector. 
 
Figure 35 depicts the corresponding resolutions. 
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Fig. 35: Resolution (R) obtained for acidic analytes on QD-based ZWIX CSPs. 
 
 
 
 
 
2.2.2) Zwitterionic (Amphoteric) Analytes 
 
Enantioseparation performance of the quinidine-based stationary phases for the ampho-
teric analytes was rather low, although homotau-QD was the only CSP that was able to 
enantioseparate free tyrosine (Figure 36). 
In comparison, tau-QD provided the most satisfactory (or rather, least disappointing) 
results. 
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Selectivity of Homologuous QD-based CSPs for Zwitterionic 
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Fig. 36: Enantioselectivities of tau-QD, homotau-QD and homohomotau-QD for 
zwitterionic analytes. (mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 
mL/min). 
 
 
It is remarkable though that no baseline separation of β-phenylalanine enantiomers 
could be achieved with tau-QD, whereas this analyte was particularly well separated 
on the two homologous QD CSPs.  
Figure 37 shows the resolution values obtained for zwitterionic analytes on the QD-
based ZWIX CSPs. 
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Fig. 37: Resolution (R) obtained for zwitterionic analytes on QD-based ZWIX CSPs. 
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2.2.3) Peptides 
 
 
Whereas homohomotau-QD was able to separate the largest number of peptide enanti-
omers (13 out of 14), the highest overall selectivities and best resolutions were obtained 
with homotau-QD (Figures 38 and 39). 
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Fig. 38: Enantioselectivities of tau-QD, homotau-QD and homohomotau-QD for all-L 
and all-D peptide enantiomers (mobile phase: methanol, 50 mM FA, 25 mM DEA, 1 
mL/min, CAD detection). 
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Fig. 39: Resolution (R) obtained for peptides on QD-based ZWIX CSPs. 
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3) Peptide Enantioseparation 
 
Today, the standard stationary phases for enantioselective HPLC separations of pep-
tides are macrocyclic antibiotics such as vancomycin (V), teicoplanine (T) or teicoplanin 
aglycone (TAG) (for structures, see introduction). 
As chiral amphoteric compounds though, peptides represent a class of analytes predes-
tined for separation on chiral zwitterionic stationary phases. 
Therefore, a set of all-L and all-D peptides (Figure 31) was subject to analysis on Chiro-
biotic TM stationary phases and the separation results were compared to those of the 
same peptides separated on our ZWIX stationary phases. 
 
Furthermore, the influence of peptide size (number of amino acids) on the retention and 
separation of homologous alanine and valine peptides was investigated. 
 
ZWIX stationary phases are normally operated with a mobile phase of methanol with 
acidic and basic additives such as formic acid and diethylamine at a ratio of 2:1. The 
addition of water to the mobile phase is expected to interfere with the ionic interactions 
of the analyte and the stationary phase and therefore to influence retention and separa-
tion. This aspect was investigated in mobile phases with water content ranging from 0-
100 % and pH values from 3,4 to 5,4. 
 
 
3.1) Peptide Enantioseparation on ChirobioticTM CSPs 
 
 
D and L enantiomers of Gly-Val were analysed on Chirobiotic V with the mobile phases 
given in Fig. 40. 
In all cases, only one single peak was detected. Judging from the retention times of sin-
gle enantiomers, it is improbable that enantioseparation was achieved, although it has 
to be said that analysis time was limited to 60 minutes, which was regarded as the up-
per limit for a feasible separation. 
Peak-shapes were frequently irregular even though only 15 µL of the analyte solutions 
were injected into the HPLC system. Ionic additives (formic acid, diethylamine) did not 
improve separation. 
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Mobile Phase 
# 
methanol 
(%) 
water 
(%) 
mobile phase 
additive(s) 
 
1 
 
100 
 
0 
 
- 
 
2 
 
90 
 
10 
 
- 
 
3 
 
50 
 
50 
 
- 
 
4 
 
10 
 
90 
 
- 
 
5 
 
0 
 
100 
 
- 
 
6 
 
90 
 
10 
50 mM FA, 
25 mM DEA 
 
Fig. 40: Mobile phase compositions for peptide enantiomer separation on 
CSPs based on macrocyclic antibiotics. 
 
 
Results were similarly dissatisfactory for Gly-Leu, Ala-Val and homologous Ala (Ala-2 to 
Ala-6) and Val (Val-2 to Val-4) peptides. In those cases where both enantiomer peaks 
were found, the most striking results were the rapidly decreasing numbers of theoretical 
plates N1 and N2. As an example, Figure 41 depicts the chromatogram of Ala-3 on Chi-
robiotic V with mobile phase MP3. 
 
 
 
Fig. 41: Enantioseparation of Ala-3 on Chirobiotic V. 
min2.5 5 7.5 10 12.5 15 17.5 20 22.5 
 
D 
tR = 12,14 min
N2 = 1353 m-1 
t0 
L 
tR = 5,72 min 
N1=24547 m-1 
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Peptide elution orders on the Chirobiotic columns should be all-L before all-D as the 
biological activity of the chiral antibiotics used in these CSPs is based on a particularly 
strong interaction with terminal D-Ala-D-Ala moieties of bacteria cell walls (introduction 
3.2.1 a). This was confirmed in those (few) cases where both enantiomer peaks could 
be detected (Figure 41). 
 
On Chirobiotic TAG, satisfactory separation of peptide enantiomers within run times of 
60 minutes was never achieved. Peak-shapes were irregular despite small amounts of 
analytes injected and frequently, only one peak was detected instead of two. 
Here, as with Chirobiotic V, separation performance of the system was not be signifi-
cantly improved by acidic (FA) or basic (DEA) additives. 
 
Altogether, separation of peptides on macrocyclic antibiotic-based chiral stationary 
phases was very time-consuming and did not yield particulary satisfactory results. 
Optimisation of the separation systems with stationary phases Chirobiotic V and Chiro-
biotic TAG would have exceeded the scope of this work – with modifications regarding 
the mobile phase composition (water content, additives, pH) better separation with 
shorter run times should be feasible. 
 
 
 
3.2) Peptide Enantioseparation on Cinchona Alkaloid-Based ZWIX CSPs 
 
According to the results reported in section B (1.3, 2.1.3 and 2.2.3), zwitterionic chiral 
stationary phases offer relatively short retention time for peptides (thereby reducing sol-
vent consumption) and, in addition, provide the possibility of reversing the elution order 
of chiral analytes by switching from quinine-based to quinidine-based CSPs. 
 
The following sections report the outcome of several experiments intended to deepen 
our understanding of peptide enantioseparation on ZWIX CSPs. 
Most of the peptides of Figure 31 were successfully enantioseparated on ZWIX selec-
tors, as reported above. Enantioselectivity of zwitterionic stationary phases was signifi-
cantly higher for valine peptides than for alanine peptides, suggesting a crucial influence 
of the amino acid side-chains on selector-selectand interaction. 
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As was the case for other zwitterionic compounds, switching from QN-based (all-D en-
antiomer is eluted first) to QD-based CSPs (all-L enantiomer first) led to a reversal of 
peptide enantiomer elution order in all cases (Figure 42). 
 
 
tau-QN  tau-QD 
 
 
 
 
 
 
 
Val-2  
 
Fig. 42: Reversal of elution order for all-L and all-D peptide enantiomers on ZWIX 
CSPs. 
D L L D 
 
 
 
 
3.2.1) Influence of Peptide Size 
 
 
Homologous alanine and valine peptides (with 2 to 6 amino acid residues) were subject 
to enantiomer separation on tau-QN, homotau-QN and homohomotau-QN (see 2.2.4). 
The aim of the experiment was to evaluate the influence of the distances between the 
SCX and WAX sites of the selector with regard to the length of the peptide. 
 
Figure 43 shows the correlation between peptide size (number of amino acid residues) 
and retention time for homotau-QN. 
 
All-D and all-L alanine peptides both experienced decreasing retention for Ala-3 com-
pared to Ala-2 and a slightly increasing retention when moving further along from Ala-3 
to Ala-6. 
Retention of all-L-valine decreased with peptide length, but both more rapidly and to a 
larger extent than that of the Ala peptides. 
This suggests that under the conditions of the experiment, especially the longer Val-
peptides retain a conformation (possibly a helical structure) that is less favourable for 
interactions with the zwitterionic selector than that of the shorter peptides. 
 
 
 
 
96
A similar decline in retention is to be expected for the all-D enantiomers of Val-5 and 
Val-6 which were not included in this study (not available). 
 
Retention time vs Number of Amino Acids in Peptide
(homotau-QN)
1,00
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t0
 
Fig. 43: Influence of peptide size on retention time of homologous peptides. CSP: 
homotau-QN, MP: methanol, 50 mM FA, 25 mM DEA, flow rate: 1 mL/min 
 
The retention of the homologous peptides on quinine-based stationary phases is shown 
in Figure 37, where the increase in selectivity for Ala-6 and the longer valine peptides 
when switching from tau-QN to homotau-QN and homohomotau-QN is clearly visible.  
 
Although the correlation is not as distinctive as expected, the separation of peptides of 
variable length on ZWIX selectors is definitely dependent on the relative distances be-
tween SCX/WAX sites of the selector and the respective peptide interaction sites. 
 
Further investigation of this aspect of peptide enantiomer separation of ZWIX selectors 
will be carried out in the future. 
 
 
3.2.2) Influence of Mobile Phase Composition 
 
 
It has been shown before that retention of zwitterionic compounds on ZWIX CSPs is pH 
dependent as the protonation of the basic moieties and the dissociation of the acidic site 
depend on the pH. The same is of course valid for the analytes. Usually, weakly acidic 
conditions are optimal for the operation of ZWIX CSPs. 
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Employing ZWIX CSPs under reversed-phase conditions is likely to change their reten-
tion characteristics so that they can be characterised as mixed-mode RP/ion exchanger 
CSPs.44 
 
First the retention of peptides on ZWIX CSPs with mobile phases of decreasing pH was 
investigated. Mobile phases were prepared by dissolving 50 mM of formic acid and 25 
mM of diethylamine in water/methanol mixtures of different composition (Fig. 44):  
 
Mobile Phase 
# 
methanol 
(%) 
water 
(%) 
Mobile phase 
additive(s) 
apparent 
pH 
 
1 
 
100 
 
0 
 
50 mM FA, 25 mM DEA 
 
5,4 
2 90 10 50 mM FA, 25 mM DEA 5,25 
 
3 50 50 50 mM FA, 25 mM DEA 4,25 
4 10 90 50 mM FA, 25 mM DEA 3,63 
5 0 100 50 mM FA, 25 mM DEA 3,60 
Fig. 44: Mobile phases for evaluation of pH influence on peptide enantiosepa-
ration. 
 
 
Retention of peptides on tau-QN, homotau-QN and homohomotau-QN decreased along 
with the pH of the mobile phase. In most cases, enantioselectivity was reduced to α=1 
with mobile phases 3 or 4. Interestingly, at the lowest water content (mobile phase 5), 
enantioselectivity increased again, but elution order was reversed for some analytes. It 
is likely that protonation of the peptides´ carboxyl moieties generated a change in the 
retention mechanism. 
 
 
Figure 45 depicts the elution order-dependent selectivity coefficients 
(here:
)(
)(
Dk
Lk
EO =α ) of alanine and valine peptides on homotau-QN as a function of mo-
bile phase composition: 
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Fig. 45: Decrease of selectivity and eventual reversal of peptide enantiomer elution 
order as a function of mobile phase composition. CSP: homotau-QN. 
 
 
 
To assess whether the reversal of elution order was really a result of decreasing pH 
(modulation of the charge of the peptide) or rather due to a change in the retention 
mechanism towards a mixture of RP and ion exchange, mobile phases with a water 
content of 0-100% and 25 mM of DEA with a pH of 5,4 (FA) were prepared. 
All-L and all-D peptide enantiomers were subject to investigation on tau-QN, homotau-
QN and homotau-QN. 
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The retention time of Ala peptides on the QN-based CSPs decreased considerably 
when the amount of water in the mobile phase was increased (Figure 46). This is due to 
a solvatation effect of the ion exchanging sites of the zwitterionic selector. 
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Fig. 46: Retention time of homologous Ala peptides as a function of mobile phase 
composition. CSP: homotau-QN. 
 
 
This phenomenon was of similar magnitude for all five Ala peptides on all 3 QN-based 
CSPs tested (data for tau-QN and homohomotau-QN are not shown). 
Apparently, ionic interactions and hydrogen bonds between the zwitterionic selector and 
the peptides, which are the basis of retention in ion exchange mode, are severely com-
promised by hydratation of the ionic interaction sites. 
 
In some cases (that is, Ala-3 on tau-QN, Ala-2, Ala-3 and Ala-4 on homotau-QN, and 
Ala-5 and Ala-6 on homohomotau-QN), retention times rose slightly when switching 
from 90% to 100% water indicating a change in retention mechanism. Possibly weak 
RP-related hydrophobic interactions are responsible for this effect. 
 
It was mentioned before that shorter retention times on ZWIX CSPs do not necessarily 
mean lower selectivity, but in the case of tau-QN, enantioselectivity was quickly reduced 
and eventually cancelled out completely by the addition of water to the mobile phase. 
This was especially true for relatively short (Ala-2) and long (Ala-6) peptides, which 
could not be separated on tau-QN with a mobile phase water content of more than 10% 
(Figure 47). 
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Analysis results were similar for Ala peptides on homotau-QN and homohomotau-QN, 
but whereas the enantioselectivity of homotau-QN for the longer peptide enantiomers 
(Ala-4, Ala-5, Ala-6) decreased more slowly than that for the shorter ones, homohomo-
tau-QN´s enantioselectivity for all 5 peptides investigated collapsed at 10 % mobile 
phase water content. 
Interestingly, at 100% water content the two smaller peptides, Ala-2 and Ala-3 became 
separable again, which is probably due to a change in the retention mechanism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
a (tau-QN) 
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Fig. 47: Influence of mobile phase composition on selectivity of QN-based CSPs for 
homologous Ala peptides. a tau-QN b homotau-QN c homohomotau-QN 
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c (homohomotau-QN) 
 
Fig. 47 (continued): Influence of mobile phase composition on selectivity of QN-
based CSPs for homologous Ala peptides. a tau-QN b homotau-QN c homohomotau-
QN 
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Enantioselectivities of QN-based CSPs for valine peptides were always higher than 
those for alanine peptides. This remained true throughout the mobile phase variation 
experiments, even though enantioselecitivity for Val-peptides also decreased with in-
creasing water content of the mobile phase. 
 
 
On tau-QN and homotau-QN (Figure 48 a, b), selectivities were especially low at 10%, 
90% and 100% water content, whereas at a mobile phase composition of 50/50 (v/v) of 
water and methanol a slight increase in enantioselectivity was observed. 
Val-2 was particularly well separated compared to its homologues, whereas enantiose-
lectivity was weakest for Val-4. 
On homohomotau-QN, however (Figure 48 c), Val-3 was significantly better separated 
than its homologues with all mobile phases. 
Besides, the decrease in Val peptide enantioselectivity with increasing water content 
was more constant than for the other two CSPs. 
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Fig. 48: Influence of mobile phase composition on selectivity of QN-based CSPs for 
homologous Val peptides. a tau-QN b homotau-QN c homohomotau-QN 
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Mixed dipeptides Gly-Val, Gly-Leu and Ala-Val were also analysed on tau-QN, homo-
tau-QN and homohomotau-QN with various mobile phases.  
As observed for the homologous peptides, selectivity for those dipeptides decreased 
with increasing water content of the mobile phase on all 3 CSPs. 
The only exception to that was Gly-Leu, which was inseparable with all mobile phases 
on tau-QN and homohomotau-QN but could be enantioseparated on homotau-QN with 
mobile phases with more than 50 % water (Fig. 49 b). 
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Fig. 49: Influence of mobile phase composition on the enantioseparation of mixed 
dipeptides. CSPs: a tau-QN b homotau-QN c homohomotau-QN 
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Homohomotau-QN
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Fig. 49 (continued): Influence of mobile phase composition on the enantioseparation of 
mixed dipeptides. CSPs: a tau-QN b homotau-QN c homohomotau-QN 
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4) Conclusion & Outlook 
 
Preparation of zwitterionic chiral stationary phases (ZWIX CSPs) based on the fusion of 
cinchona alkaloids and taurine-homologues yielded tau-QN, homotau-QN and ho-
mohomotau-QN and their pseudo-enantiomers tau-QD, homotau-QD and homohomo-
tau-QD. 
Selectors with aminomethanesulfonic acid (AMSA) as the SCX site (AMSA-QN and 
AMSA-QD) remain yet to be synthesised, as the protocols employed for the synthesis of 
the other selectors were not successful with AMSA – most probably, the reason for the 
failure seems to be the small size of the aminomethanesulfonic acid. Systematic modifi-
cation of individual synthesis steps also did not bring about the desired results. 
  
The chiral zwitterionic stationary phases prepared in the course of this work were suc-
cessfully employed for the enantioseparation of acidic (e.g. N-protected amino acids, 
acidic drugs) as well as amphoteric (zwitterionic) compounds such as free amino acids 
and peptides. 
Therefore, ZWIX CSPs represent a powerful alternative to chiral stationary phases 
based on macrocyclic antibiotics which to date are the most widely used system for this 
kind of enantioseparation. In addition to relatively short run times, the most advanta-
geous characteristic of ZWIX CSPs is their straightforward application which does not 
require a great deal of mobile phase optimization. Besides, cinchona-based ZWIX CSPs 
offer the potential of reversing the elution order of enantiomers by switching from qui-
nine to quinidine-based phases. There is often no such possibility with the macrocyclic 
antibiotics-based CSP, although sometimes the elution order can be reversed by 
switching from e.g. a Ristocetin A to a Vancomycin or Teicoplanin column. 
 
The comparison of quinine- and quinidine-based stationary phases showed that enanti-
oselectivites on the pseudo-enantiomeric stationary phases were comparable, whereas 
the elution order was inverted. This is especially beneficial for the separation of enanti-
omeric impurities or for preprarative applications where a reversal of elution order may 
be required. 
 
Separation capabilities of tau-QN, homotau-QN and homohomotau-QN were investi-
gated with a special focus on mixed di- and tripeptides and homologous alanine and 
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valine peptides. Even though tau-QN delivered satisfactory results for acidic analytes 
and unprotected amino acids, homotau-QN and homohomotau-QN performed signifi-
cantly better in the peptide separations. 
Enantioseparation of free amino acids was often not satisfactory. This is most probably 
due to the lack of a chiral center in the vicinity of the sulfonic acid SCX site in the tau-, 
homotau- and homohomotau selectors. ZWIX CSPs which incorporated a chiral sulfonic 
acid (aminocyclohexanesulfonic acid, see introduction, section 4) obtained better enan-
tioselectivity of free amino acids than those which an achiral sulfonic acid side chain.35 
 
To fully understand the retention mechanism and enantioselectivity of ZWIX CSPs for 
peptides, an extended set of peptides sets will have to be analysed. The influence of the 
α-amid binding on chiral recognition can be investigated by analysis of peptides based 
on α- and β-amino acids. 
 
Currently, the Lindner Group is working on the widening of the spectrum of zwitterionic 
chiral stationary phases based on diverse chiral cationic and anionic scaffolds and syn-
thons, among them cinchona-based CSPs with chiral anion and cation exchanging 
moieties. 
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 A2
Abstract 
 
The separation of chiral compounds into their enantiomers has been gaining 
importance over the last two decades, mostly due to rigorous regulatory demands 
concerning chiral drugs and also chiral intermediates. 
In this work, chiral separation techniques for amino acids and peptides with their 
advantages and drawbacks are discussed. 
Depending on the surrounding environment, amino acids and peptides can be 
present in ionic form and therefore represent natural targets for HPLC separation 
methods based on an ion exchange mechanism. However, they cannot be 
enantioseparated on chiral anion or cation exchanging stationary phases because a 
second charge, acting as an intramolecular counterion, is present in these 
amphoteric compounds. 
For these analytes, zwitterionic ion exchange chiral stationary phases (ZWIX CSPs) 
have to be employed in order to achieve retention based on ionic interaction. 
In the course of this work, zwitterionic chiral stationary phases based on the fusion of 
cinchona alkaloid anion exchanging sites and homologous achiral sulfonic acids as 
cation exchanging sites were synthesised. The CSPs were evaluated for their 
enantioseparation capabilities with a set of acidic and amphoteric analytes and 
peptides under polar-organic mobile phase conditions. 
The CSPs performed satisfactorily in the enantioseparation of acidic compounds and, 
compared to a chiral anion exchanger, yielded shorter retention times. Especially 
high enantioselectivites (> 5) were obtained for halide-substituted phenylalanines and 
DNB-protected amino acids. 
Zwitterionic compounds, however, were often not baseline separated, which may be 
attributed to the absence of a chiral center in the vicinity of the sulfonic acid moieties. 
The enantioseparation of all-L and all-D enantiomers of dipeptides was accomplished 
for most of the peptides analysed, and particularly good results were obtained for 
peptides containing aromatic side chains. 
Homologous peptides based on alanine and valine were employed to investigate the 
influence of peptide length on enantioseparation with ZWIX CSPs which had 
homologous sulfonic acid moieties. 
Adding water to the methanolic mobile phase severely decreased both retention and 
enantioselectivity for peptides on the CSPs, indicating a solvatation effect of the ion 
exchanging sites which significantly reduces ionic selector-selectand interactions. 
 A3
Zusammenfassung 
Die Bedeutung von Enantiomerentrennungen hat in den letzten Jahrzehnten stark 
zugenommen, was vor allem den immer strenger werdenden Anforderungen der 
Regulierungsbehörden in Bezug auf die Charakterisierung chiraler Arzneistoffe 
zuzuschreiben ist. 
In der vorliegenden Arbeit wird eine Auswahl chiraler Trenntechniken für 
Aminosäuren und Peptide vorgestellt und ihre Vor- und Nachteile kurz beschrieben. 
Aufgrund ihrer ionisierbaren funktionellen Gruppen stellen Aminosäuren und Peptide 
nahe liegende Zielanalyten für HPLC-Enantiomerentrennungen mittels chiraler 
Ionenaustauscherphasen dar. Allerdings sind die Verbindungen amphoter 
(zwitterionisch), können also gleichzeitig positive und negative Ladungen tragen. 
Diese können ihrerseits mit weiteren Ladungsträgern interagieren. 
Solche Verbindungen können nicht mit reinen Anionen- oder Kationenaustauschern 
getrennt werden, da die zweite Ladung als intramolekulares Gegenion wirkt und 
damit eine Retention verhindert. 
Für derartige Trennungen werden zwitterionische chirale Ionenaustauscherphasen 
benötigt, welche ebenso saure und basische Gruppen tragen, sodass eine simultane 
kooperative Ionenpaarbildung möglich wird. 
Im Laufe der vorliegenden Diplomarbeit wurden 6 derartige Phasen für die HPLC 
hergestellt, indem homologe Sulfonsäuren als Kationenaustauscher und Chinin 
sowie sein Pseudoenantiomer Chinidin als Anionenaustauscher miteinander 
verbunden wurden. 
Diese chiralen Phasen wurden mit einem Analytenset bestehend aus chiralen 
Säuren und amphoteren Verbindungen sowie Peptiden hinsichtlich ihrer 
Trennleistung im polar-organischen Modus charakterisiert. 
Obwohl für saure Analyte wie N-geschützte Aminosäuren zufrieden stellende 
Ergebnisse erzielt wurden, konnten freie Aminosäuren oft nicht basisliniengetrennt 
werden. Die Gründe hierfür liegen zum Teil im Fehlen eines chiralen Zentrums in der 
Nähe der Kationenaustauscherseite, bemerkenswerte Ausnahmen waren aber 
Halogen-substituierte Aminosäuren (z.B. Brom-Phenylalanin), für die teilweise 
Enantioselektivitäten über 5 erzielt werden konnten 
Die zugrunde liegenden molekularen Erkennungsmechanismen dieses Verhaltens 
bedürfen noch näherer Betrachtung. 
 A4
Peptidenantiomere konnten in vielen Fällen basisliniengetrennt werden, wobei die 
funktionellen Gruppen der Seitenkette eine entscheidende Rolle bei der Trennung 
spielten. 
Weiters wurde der Einfluss der mobilen Phase auf die Retention und 
Enantioselektivität von homologen Peptiden getestet, indem der methanolischen 
mobilen Phase unterschiedliche Anteile von Wasser zugefügt wurden. Dies 
beeinträchtigte die Trennung der Peptide massiv, was mit der zunehmenden 
Solvatisierung der ionischen Gruppen des Selektors und den damit abnehmenden 
polaren Wechselwirkungen zwischen Selektor und Analyten erklärt werden kann. 
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